@NP	Scar ablation combined with LP/OEC transplantation	1
@NP	Scar ablation	1
@NP	LP/OEC transplantation	29
@NP	anatomical recovery and P0-positive myelination	61
@NP	chronically contused spinal cord of rats Shu-xin	112
@NP	chronically contused spinal cord	112
@NP	rats Shu-xin	148
@NP	Zhanga , , Fengfa Huanga , Mary Gatesa , Eric G.	162
@NP	Zhanga	162
@NP	, Fengfa Huanga , Mary Gatesa , Eric G.	170
@NP	Fengfa Huanga , Mary Gatesa	172
@NP	Fengfa Huanga	172
@NP	Mary Gatesa	187
@NP	Holmberga	208
@NP	b	219
@NP	We	222
@NP	an existing glial scar	251
@NP	chronically contused rat spinal cord	277
@NP	a rose Bengal-based phototoxic method	320
@NP	a rose	320
@NP	The purpose of this study	359
@NP	The purpose	359
@NP	this study	374
@NP	scar ablation benefits	402
@NP	the anatomical recovery by cell/tissue transplantation	425
@NP	the anatomical recovery	425
@NP	cell/tissue transplantation	452
@NP	a more permissive physical and biochemical environment	499
@NP	axonal growth , which may lead to functional recovery	558
@NP	axonal growth	558
@NP	functional recovery	591
@NP	scar ablation	630
@NP	we	645
@NP	lamina propria -LRB- LP -RRB- of the olfactory mucosa alone or in combination	661
@NP	lamina propria -LRB- LP -RRB-	661
@NP	lamina propria	661
@NP	LP	677
@NP	the olfactory mucosa alone or in combination	684
@NP	the olfactory mucosa	684
@NP	combination	717
@NP	olfactory ensheathing cells -LRB- OEC -RRB-	743
@NP	olfactory ensheathing cells	743
@NP	OEC	772
@NP	the lesion cavity	782
@NP	6 weeks	800
@NP	contusion injury	814
@NP	NYU impactor device , 25 mm height setting	832
@NP	NYU impactor device	832
@NP	25 mm height setting	853
@NP	spinal cord segment T10 of adult female Long -- Evans rats	878
@NP	spinal cord segment T10	878
@NP	adult female Long -- Evans rats	905
@NP	Long	918
@NP	Evans rats	923
@NP	Evans	923
@NP	rats	929
@NP	Sixteen weeks	935
@NP	scar ablation and transplantation	955
@NP	we	990
@NP	the initial repaired tissue	1004
@NP	remarkable reduction or disappearance	1069
@NP	the lesion cavity and integration of repaired tissue with the spared tissue	1110
@NP	the lesion cavity and integration	1110
@NP	repaired tissue with the spared tissue	1147
@NP	repaired tissue	1147
@NP	the spared tissue	1168
@NP	histological repair of damaged cord tissue at the injury epicenter	1205
@NP	histological repair	1205
@NP	damaged cord tissue at the injury epicenter	1228
@NP	damaged cord tissue	1228
@NP	the injury epicenter	1251
@NP	Glial scar reformation	1273
@NP	ablation due to the tissue repair	1328
@NP	ablation	1328
@NP	the tissue repair	1344
@NP	addition	1366
@NP	the injury epicenter P0	1379
@NP	myelin glycoprotein P-zero	1404
@NP	positive myelination formed by Schwann cells	1432
@NP	positive myelination	1432
@NP	Schwann cells	1463
@NP	myelinate regenerating	1497
@NP	axons	1537
@NP	number	1576
@NP	the control animals	1597
@NP	BBB open-field scale	1647
@NP	a significant improvement of locomotor function	1668
@NP	a significant improvement	1668
@NP	locomotor function	1697
@NP	this study	1736
@NP	the possible reasons	1748
@NP	Introduction	1789
@NP	many treatment approaches including cell transplantation	1808
@NP	many treatment approaches	1808
@NP	cell transplantation	1844
@NP	functional recovery in acute spinal cord injury -LRB- SCI -RRB- models	1895
@NP	recovery in acute spinal cord	1906
@NP	recovery	1906
@NP	acute spinal cord	1918
@NP	SCI	1944
@NP	the same or similar treatments	1957
@NP	chronic spinal cord injury models	2021
@NP	Azanchi et al. , 2004 ; Houle and Tessler , 2003 ; Tetzlaff et al. , 2010	2056
@NP	Azanchi	2056
@NP	et al. , 2004 ; Houle and Tessler , 2003 ; Tetzlaff et al. , 2010	2064
@NP	et al. , 2004	2064
@NP	et al.	2064
@NP	2004	2072
@NP	Houle and Tessler , 2003	2078
@NP	Houle and Tessler	2078
@NP	2003	2097
@NP	Tetzlaff et al. , 2010	2103
@NP	Tetzlaff	2103
@NP	et al. , 2010	2112
@NP	et al.	2112
@NP	2010	2120
@NP	studies	2136
@NP	neurons with axonotmesis in the chronically injured spinal cord	2155
@NP	neurons	2155
@NP	axonotmesis in the chronically injured spinal cord	2168
@NP	axonotmesis	2168
@NP	the chronically injured spinal cord	2183
@NP	the ability	2234
@NP	the glial scar	2261
@NP	the elongation	2295
@NP	regenerating axons	2313
@NP	Bareyre , 2008	2333
@NP	Bareyre	2333
@NP	2008	2342
@NP	Houle , 1991	2348
@NP	Houle	2348
@NP	1991	2355
@NP	Kobayashi et al. , 1997	2361
@NP	Kobayashi	2361
@NP	et al. , 1997	2371
@NP	et al.	2371
@NP	1997	2379
@NP	Siebert et al. , 2010	2385
@NP	Siebert	2385
@NP	et al. , 2010	2393
@NP	et al.	2393
@NP	2010	2401
@NP	Silver and Miller	2407
@NP	Silver	2407
@NP	Miller	2418
@NP	2004 ; Steeves	2426
@NP	2004	2426
@NP	Steeves	2432
@NP	Zwimpfer , 1997	2444
@NP	Zwimpfer	2444
@NP	1997	2454
@NP	The cessation of axonal elongation via glial inhibition	2461
@NP	The cessation	2461
@NP	axonal elongation via glial inhibition	2478
@NP	axonal elongation	2478
@NP	glial inhibition	2500
@NP	the failure of functional recovery	2551
@NP	the failure	2551
@NP	functional recovery	2566
@NP	a chronically injured spinal cord	2589
@NP	Bradbury and Carter	2624
@NP	2011	2645
@NP	Davies	2651
@NP	et al. , 1997 ; Houle and Reier , 1988 ; McKerracher , 2001 ; Silver and Miller	2658
@NP	et al. , 1997	2658
@NP	et al.	2658
@NP	1997	2666
@NP	Houle and Reier , 1988	2672
@NP	Houle and Reier	2672
@NP	1988	2689
@NP	McKerracher , 2001	2695
@NP	McKerracher	2695
@NP	2001	2708
@NP	Silver and Miller	2714
@NP	Silver	2714
@NP	Miller	2725
@NP	2004	2733
@NP	Several studies	2740
@NP	significant axonal growth into the graft	2776
@NP	significant axonal growth	2776
@NP	the graft	2807
@NP	the removal of inhibitory chondroitin sulfate proteoglycans -LRB- CSPG -RRB-	2826
@NP	the removal	2826
@NP	inhibitory chondroitin sulfate proteoglycans -LRB- CSPG -RRB-	2841
@NP	inhibitory chondroitin sulfate proteoglycans	2841
@NP	CSPG	2887
@NP	astrocytic scar tissue	2897
@NP	the lesion site prior to transplantation	2925
@NP	the lesion site	2925
@NP	transplantation	2950
@NP	Bradbury	2967
@NP	et al. , 2002	2976
@NP	et al.	2976
@NP	2002	2984
@NP	Carter et al. , 2011	2990
@NP	Carter	2990
@NP	et al. , 2011	2997
@NP	et al.	2997
@NP	2011	3005
@NP	Garcia-Alias et al. , 2009	3011
@NP	Garcia-Alias	3011
@NP	et al. , 2009	3024
@NP	et al.	3024
@NP	2009	3032
@NP	Houle and Tessler , 2003	3038
@NP	Houle and Tessler	3038
@NP	2003	3057
@NP	Hulsebosch , 2002	3063
@NP	Hulsebosch	3063
@NP	2002	3075
@NP	Tom et al. , 2009	3081
@NP	Tom	3081
@NP	et al. , 2009	3085
@NP	et al.	3085
@NP	2009	3093
@NP	These results	3100
@NP	both scar ablation and cell transplantation	3127
@NP	scar ablation	3132
@NP	cell transplantation	3150
@NP	one necessary component for successful treatment of a chronic spinal cord injury	3180
@NP	one necessary component	3180
@NP	successful treatment of a chronic spinal cord injury	3208
@NP	successful treatment	3208
@NP	a chronic spinal cord injury	3232
@NP	The glial scar	3262
@NP	an important target	3293
@NP	regeneration research in spinal cord injury	3317
@NP	regeneration research	3317
@NP	spinal cord injury	3342
@NP	few studies	3371
@NP	successful removal	3414
@NP	an existing glial scar	3436
@NP	Fawcett and Asher	3460
@NP	1999	3479
@NP	Gimenez y Ribotta	3485
@NP	et al. , 2002	3503
@NP	et al.	3503
@NP	2002	3511
@NP	Hu et al. , 2010	3517
@NP	Hu	3517
@NP	et al. , 2010	3520
@NP	et al.	3520
@NP	2010	3528
@NP	Kwon and Tetzlaff , 2001	3534
@NP	Kwon and Tetzlaff	3534
@NP	2001	3553
@NP	Schwab and Bartholdi	3559
@NP	Schwab	3559
@NP	Bartholdi	3570
@NP	1996	3581
@NP	its irregularity in shape	3599
@NP	its irregularity	3599
@NP	shape	3619
@NP	glial scar removal by surgical or laser resection	3626
@NP	glial scar removal	3626
@NP	surgical or laser resection	3648
@NP	surgical	3648
@NP	laser resection	3660
@NP	We	3699
@NP	a partial removal of the glial scar	3727
@NP	a partial removal	3727
@NP	the glial scar	3748
@NP	the chronically contused rat	3766
@NP	spinal cord using	3795
@NP	spinal cord	3795
@NP	Bengal-dependent phototoxic ablation	3818
@NP	the lesion cavity	3882
@NP	Bengal	3906
@NP	the surface	3939
@NP	2 -- 3 layer of astrocytes comprising the glial scar	3951
@NP	2	3951
@NP	3 layer of astrocytes comprising the glial scar	3953
@NP	3 layer	3953
@NP	astrocytes comprising the glial scar	3964
@NP	astrocytes	3964
@NP	the glial scar	3986
@NP	Exposure of intracellular	4002
@NP	Exposure	4002
@NP	Bengal	4033
@NP	visible light results	4043
@NP	the production	4068
@NP	singlet oxygen	4086
@NP	living systems including nucleic acids , proteins , and lipids	4127
@NP	living systems	4127
@NP	nucleic acids , proteins , and lipids	4152
@NP	nucleic acids	4152
@NP	proteins	4167
@NP	lipids	4181
@NP	glial scar cells	4194
@NP	Bengal toxicity	4232
@NP	prominent damage to the spared tissue	4260
@NP	prominent damage	4260
@NP	the spared tissue	4280
@NP	the residual axons -LRB- Zhang et al. , 2007 -RRB-	4309
@NP	the residual axons	4309
@NP	Zhang	4329
@NP	et al. , 2007	4335
@NP	et al.	4335
@NP	2007	4343
@NP	We	4350
@NP	scar ablation	4376
@NP	migration of Schwann cells	4400
@NP	migration	4400
@NP	Schwann cells	4413
@NP	the spared tissue	4432
@NP	the presence of P0 -LRB- myelin glycoprotein P-zero -RRB- - positive myelination	4468
@NP	the presence	4468
@NP	P0 -LRB- myelin glycoprotein P-zero -RRB- - positive myelination	4484
@NP	P0	4484
@NP	myelin glycoprotein P-zero	4488
@NP	positive myelination	4516
@NP	The infiltration of Schwann cells	4538
@NP	The infiltration	4538
@NP	Schwann cells	4558
@NP	the elimination of the glial scar as a physical barrier	4604
@NP	the elimination	4604
@NP	the glial scar as a physical barrier	4623
@NP	the glial scar	4623
@NP	a physical barrier	4641
@NP	These findings	4661
@NP	us	4681
@NP	the ablation of the glial scar tissue	4704
@NP	the ablation	4704
@NP	the glial scar tissue	4720
@NP	a more appropriate environment for the anatomical recovery	4754
@NP	a more appropriate environment	4754
@NP	the anatomical recovery	4789
@NP	cell/tissue transplantation	4816
@NP	a more permissive physical and biochemical environment for axonal growth	4862
@NP	a more permissive physical and biochemical environment	4862
@NP	axonal growth	4921
@NP	functional recovery	4947
@NP	the past decade	4975
@NP	lamina	4992
@NP	propria -LRB- LP -RRB-	4999
@NP	propria	4999
@NP	LP	5008
@NP	olfactory ensheathing cells -LRB- OECs -RRB-	5020
@NP	olfactory ensheathing cells	5020
@NP	OECs	5049
@NP	lamina propria of olfactory mucosa	5059
@NP	lamina propria	5059
@NP	olfactory mucosa	5077
@NP	much attention	5109
@NP	a number of investigators	5129
@NP	a number	5129
@NP	investigators	5141
@NP	they	5156
@NP	a leading cell or tissue candidate	5182
@NP	transplantation	5221
@NP	the gap in spinal cord injury	5247
@NP	the gap	5247
@NP	spinal cord injury	5258
@NP	their potential reparative properties and function	5284
@NP	Boyd	5336
@NP	et al. , 2005	5341
@NP	et al.	5341
@NP	2005	5349
@NP	Lima et al. , 2009	5355
@NP	Lima	5355
@NP	et al. , 2009	5360
@NP	et al.	5360
@NP	2009	5368
@NP	Lu et al. , 2002	5374
@NP	Lu	5374
@NP	et al. , 2002	5377
@NP	et al.	5377
@NP	2002	5385
@NP	Mackay-Sim et al. , 2008	5391
@NP	Mackay-Sim	5391
@NP	et al. , 2008	5402
@NP	et al.	5402
@NP	2008	5410
@NP	Richter et al. , 2005	5416
@NP	Richter	5416
@NP	et al. , 2005	5424
@NP	et al.	5424
@NP	2005	5432
@NP	LP OECs	5439
@NP	neurotrophins	5471
@NP	neurotrophin 3 -LRB- NT-3 -RRB-	5494
@NP	neurotrophin 3	5494
@NP	NT-3	5510
@NP	neurotrophin 4 -LRB- NT-4 -RRB-	5517
@NP	neurotrophin 4	5517
@NP	NT-4	5533
@NP	nerve growth factor -LRB- NGF -RRB-	5540
@NP	nerve growth factor	5540
@NP	NGF	5561
@NP	brain-derived neurotrophic factor -LRB- BDNF -RRB-	5567
@NP	brain-derived neurotrophic factor	5567
@NP	BDNF	5602
@NP	glial	5613
@NP	neurotrophic factor -LRB- GDNF -RRB- -LRB- Lipson et al. , 2003 -RRB-	5627
@NP	neurotrophic factor -LRB- GDNF -RRB-	5627
@NP	neurotrophic factor	5627
@NP	GDNF	5648
@NP	Lipson	5655
@NP	et al. , 2003	5662
@NP	et al.	5662
@NP	2003	5670
@NP	Studies	5677
@NP	transplanted LP OECs or olfactory bulb -LRB- OB -RRB-	5701
@NP	transplanted LP OECs	5701
@NP	olfactory bulb -LRB- OB -RRB-	5725
@NP	olfactory bulb	5725
@NP	OB	5741
@NP	OECs	5754
@NP	transplantation	5777
@NP	the adult mammalian CNS	5798
@NP	astrocytes	5843
@NP	the animal model	5857
@NP	SCI	5877
@NP	Boyd	5882
@NP	et al. , 2003	5887
@NP	et al.	5887
@NP	2003	5895
@NP	Lakatos et al. , 2000	5901
@NP	Lakatos	5901
@NP	et al. , 2000	5909
@NP	et al.	5909
@NP	2000	5917
@NP	Richter et al. , 2005	5923
@NP	Richter	5923
@NP	et al. , 2005	5931
@NP	et al.	5931
@NP	2005	5939
@NP	Richter and Roskams , 2008	5945
@NP	Richter and Roskams	5945
@NP	2008	5966
@NP	Wewetzer et al. , 2002	5972
@NP	Wewetzer	5972
@NP	et al. , 2002	5981
@NP	et al.	5981
@NP	2002	5989
@NP	Both LP and OB OEC transplantation	5996
@NP	axonal regeneration , remyelination and functional recovery	6060
@NP	various models	6122
@NP	acute spinal cord injury	6140
@NP	Gorrie	6166
@NP	et al. , 2010	6173
@NP	et al.	6173
@NP	2010	6181
@NP	Lindsay et al. , 2010	6187
@NP	Lindsay	6187
@NP	et al. , 2010	6195
@NP	et al.	6195
@NP	2010	6203
@NP	Ramon-Cueto et al. , 1998	6209
@NP	Ramon-Cueto	6209
@NP	et al. , 1998	6221
@NP	et al.	6221
@NP	1998	6229
@NP	Ramon-Cueto et al. , 2000	6235
@NP	Ramon-Cueto	6235
@NP	et al. , 2000	6247
@NP	et al.	6247
@NP	2000	6255
@NP	Santos-Benito and Ramon-Cueto , 2003	6262
@NP	Santos-Benito and Ramon-Cueto	6262
@NP	2003	6293
@NP	Wewetzer et al. , 2002	6299
@NP	Wewetzer	6299
@NP	et al. , 2002	6308
@NP	et al.	6308
@NP	2002	6316
@NP	LP OECs and OB OECs	6323
@NP	LP OECs	6323
@NP	OB OECs	6335
@NP	many common properties	6349
@NP	some differences -LRB- Richter et al. , 2005 ; Rizek and Kawaja , 2006 -RRB-	6377
@NP	some differences	6377
@NP	Richter	6395
@NP	et al. , 2005 ; Rizek and Kawaja , 2006	6403
@NP	et al.	6403
@NP	2005 ; Rizek and Kawaja	6411
@NP	2005	6411
@NP	Rizek and Kawaja	6417
@NP	2006	6435
@NP	further clinical application	6455
@NP	it	6484
@NP	reparative cells or tissues	6517
@NP	an olfactory mucosal biopsy via intranasal endoscopy	6550
@NP	an olfactory mucosal biopsy	6550
@NP	intranasal endoscopy	6582
@NP	the more invasive intracranial approach	6625
@NP	an olfactory bulb -LRB- Yamamoto et al. , 2009 -RRB-	6675
@NP	an olfactory bulb	6675
@NP	Yamamoto	6694
@NP	et al. , 2009	6703
@NP	et al.	6703
@NP	2009	6711
@NP	the effects of LP OEC transplantation on a chronic contusion model of rat SCI	6725
@NP	the effects	6725
@NP	LP OEC transplantation on a chronic contusion model of rat SCI	6740
@NP	LP OEC transplantation	6740
@NP	a chronic contusion model of rat SCI	6766
@NP	a chronic contusion model	6766
@NP	rat SCI	6795
@NP	Lu et al. , 2002 ; Plant et al. , 2003	6834
@NP	Lu	6834
@NP	et al. , 2002 ; Plant et al. , 2003	6837
@NP	et al. , 2002	6837
@NP	et al.	6837
@NP	2002	6845
@NP	Plant et al. , 2003	6851
@NP	Plant	6851
@NP	et al. , 2003	6857
@NP	et al.	6857
@NP	2003	6865
@NP	The purpose of this study	6872
@NP	The purpose	6872
@NP	this study	6887
@NP	transplantation	6917
@NP	LP / OECs into a chronically contused rat spinal cord after scar ablation	6936
@NP	LP	6936
@NP	OECs into a chronically contused rat spinal cord	6940
@NP	OECs	6940
@NP	a chronically contused rat spinal cord	6950
@NP	scar ablation	6995
@NP	the anatomical recovery , axonal regeneration and functional recovery	7023
@NP	recovery , axonal regeneration	7038
@NP	Results Table 1 -- Animal grouping .	7097
@NP	Results Table 1	7097
@NP	Results	7097
@NP	Table 1	7105
@NP	Animal grouping	7115
@NP	Animal	7115
@NP	grouping	7122
@NP	Table 2 -- Primary antibodies used .	7133
@NP	Table 2	7133
@NP	Primary antibodies used	7143
@NP	Primary antibodies	7143
@NP	Fig. 1 -- Olfactory lamina propria and cultured OECs .	7169
@NP	Fig. 1	7169
@NP	Olfactory lamina propria and cultured OECs	7178
@NP	Olfactory lamina	7178
@NP	propria	7195
@NP	OECs	7216
@NP	Panel A -LRB- paraffin section , H.E. staining -RRB-	7222
@NP	Panel A	7222
@NP	paraffin section	7231
@NP	H.E. staining	7249
@NP	the olfactory mucosa	7270
@NP	olfactory epithelium and lamina propria	7305
@NP	a large number	7360
@NP	olfactory nerve fibers -LRB- longitudinal profile -RRB-	7378
@NP	olfactory nerve fibers	7378
@NP	longitudinal profile	7402
@NP	blood vessels	7425
@NP	Bowman 's glands -LRB- * -RRB-	7444
@NP	Bowman 's glands	7444
@NP	Bowman 's	7444
@NP	Panel B	7465
@NP	the lamina propria	7476
@NP	transplantation -LRB- paraffin section , H.E. staining -RRB-	7508
@NP	transplantation	7508
@NP	paraffin section	7525
@NP	H.E. staining	7543
@NP	olfactory epithelium removed	7563
@NP	olfactory epithelium	7563
@NP	the olfactory nerve fibers -LRB- cross profile -RRB-	7597
@NP	the olfactory nerve fibers	7597
@NP	cross profile	7625
@NP	Panel C	7667
@NP	the representative fluorescent image	7678
@NP	OECs , which were immunostained	7727
@NP	OECs	7727
@NP	expression of p75NTR -LRB- red -RRB- and GFAP -LRB- green -RRB-	7773
@NP	expression	7773
@NP	p75NTR -LRB- red -RRB- and GFAP -LRB- green -RRB-	7787
@NP	p75NTR	7787
@NP	red	7795
@NP	GFAP	7804
@NP	All nuclei	7818
@NP	Hoechst -LRB- blue -RRB-	7847
@NP	Hoechst	7847
@NP	Scale bars : 100 μm .	7863
@NP	Scale bars	7863
@NP	100 μm	7875
@NP	Fig. 2 -- Scar ablation and LP transplantation .	7884
@NP	Fig. 2	7884
@NP	Scar ablation and LP transplantation	7893
@NP	Glial scars with sharp edge	7931
@NP	Glial scars	7931
@NP	sharp edge	7948
@NP	arrows -LRB- A , H.E. staining ; B , GFAP immunostaining -RRB-	7978
@NP	arrows	7978
@NP	A , H.E. staining ; B , GFAP immunostaining	7986
@NP	A	7986
@NP	H.E. staining ; B	7989
@NP	H.E. staining	7989
@NP	B	8004
@NP	GFAP immunostaining	8007
@NP	Eight minutes after being injected into the lesion cavity	8029
@NP	Eight minutes	8029
@NP	the lesion cavity	8069
@NP	Bengal -LRB- in pink -RRB-	8093
@NP	Bengal	8093
@NP	pink	8104
@NP	the superficial cells	8126
@NP	the morphology of astrocytes -LRB- larger arrows in C -RRB- of the glial scar	8153
@NP	the morphology	8153
@NP	astrocytes -LRB- larger arrows in C -RRB- of the glial scar	8171
@NP	astrocytes -LRB- larger arrows in C -RRB-	8171
@NP	astrocytes	8171
@NP	larger arrows in C	8183
@NP	larger arrows	8183
@NP	C	8200
@NP	the glial scar	8206
@NP	Macrophages -LRB- MΦ -RRB- within the lesion cavity	8222
@NP	Macrophages -LRB- MΦ -RRB-	8222
@NP	Macrophages	8222
@NP	MΦ	8235
@NP	the lesion cavity	8246
@NP	some other astrocyte-like cells -LRB- small arrows -RRB-	8268
@NP	some other astrocyte-like cells	8268
@NP	small arrows	8301
@NP	the superficial cells	8326
@NP	different degree	8369
@NP	no cell in deeper	8391
@NP	no cell	8391
@NP	deeper	8402
@NP	tissue	8416
@NP	the rose Bengal	8438
@NP	the rose	8438
@NP	Bengal	8447
@NP	illumination	8465
@NP	Bengal-stained cells of the glial scar	8483
@NP	Bengal-stained cells	8483
@NP	the glial scar	8507
@NP	area between arrows and broken line in D ; H.E. staining	8546
@NP	area between arrows	8546
@NP	area	8546
@NP	arrows	8559
@NP	broken line in D ; H.E. staining	8570
@NP	broken line in D	8570
@NP	broken line	8570
@NP	D	8585
@NP	H.E. staining	8588
@NP	H.E.	8588
@NP	staining	8593
@NP	a part of damaged glial scar	8604
@NP	a part	8604
@NP	damaged glial scar	8614
@NP	arrowheads and broken line	8659
@NP	arrowheads	8659
@NP	broken line	8674
@NP	the spared tissue being exposed	8701
@NP	the spared tissue	8701
@NP	The transplanted LP	8734
@NP	the lesion cavity close	8772
@NP	the spared tissue	8799
@NP	Some of the degenerating or demyelinated axons in the spared tissue	8818
@NP	Some	8818
@NP	the degenerating	8826
@NP	axons in the spared tissue	8859
@NP	axons	8859
@NP	the spared tissue	8868
@NP	asterisks -LRB- * -RRB-	8902
@NP	asterisks	8902
@NP	Scale bars : 0.1 mm -LRB- A , B -RRB- , 0.2 mm -LRB- C , D -RRB- .	8917
@NP	Scale bars	8917
@NP	0.1 mm -LRB- A , B -RRB- , 0.2 mm -LRB- C , D -RRB-	8929
@NP	0.1 mm	8929
@NP	A , B	8936
@NP	A	8936
@NP	B	8939
@NP	0.2 mm -LRB- C , D -RRB-	8943
@NP	Fig. 3 -- Survival of transplanted GFP-positive cells .	8958
@NP	Fig. 3	8958
@NP	Survival of transplanted GFP-positive cells	8967
@NP	Survival	8967
@NP	transplanted GFP-positive cells	8979
@NP	Eight weeks	9012
@NP	transplantation of GFP-LP	9030
@NP	transplantation	9030
@NP	GFP-LP	9049
@NP	the lesion cavity following the scar ablation	9061
@NP	the lesion cavity	9061
@NP	the scar ablation	9089
@NP	GFP-positive cells -LRB- green in A , sagittal cryosection -RRB-	9108
@NP	GFP-positive cells	9108
@NP	green in A , sagittal cryosection	9128
@NP	green in A	9128
@NP	sagittal cryosection	9140
@NP	the spared tissue marked by GFAP -LRB- red -RRB-	9203
@NP	the spared tissue	9203
@NP	GFAP -LRB- red -RRB-	9231
@NP	GFAP	9231
@NP	red	9237
@NP	higher magnification	9249
@NP	most of GFP-positive cells	9271
@NP	most	9271
@NP	GFP-positive cells	9279
@NP	their orientation parallel	9311
@NP	the longitudinal axis of the spinal cord	9341
@NP	the longitudinal axis	9341
@NP	the spinal cord	9366
@NP	the NF-positive axons -LRB- red in B , pointed by arrows -RRB-	9420
@NP	the NF-positive axons	9420
@NP	red in B , pointed by arrows	9443
@NP	red	9443
@NP	B , pointed by arrows	9450
@NP	B	9450
@NP	arrows	9464
@NP	Scale bars : 0.5 mm -LRB- A -RRB- , 0.1 mm -LRB- B -RRB- .	9473
@NP	Scale bars	9473
@NP	0.5 mm -LRB- A -RRB- , 0.1 mm -LRB- B -RRB-	9485
@NP	0.5 mm	9485
@NP	A	9492
@NP	0.1 mm -LRB- B -RRB-	9496
@NP	B	9503
@NP	Fig. 4 -- Tissue repair after scar ablation and transplantation .	9508
@NP	Fig. 4	9508
@NP	Tissue repair after scar ablation and transplantation	9517
@NP	Tissue repair	9517
@NP	scar ablation and transplantation	9537
@NP	A , B , C , D and E	9572
@NP	A , B , C , D	9572
@NP	E	9587
@NP	cross sections at the injury epicenter from different groups	9593
@NP	cross sections	9593
@NP	the injury epicenter from different groups	9611
@NP	the injury epicenter	9611
@NP	different groups	9637
@NP	the others in the same rows	9658
@NP	the others	9658
@NP	the same rows	9672
@NP	their local magnifications	9690
@NP	Panels in the left and middle columns	9732
@NP	Panels	9732
@NP	the left and middle columns	9742
@NP	the left	9742
@NP	middle columns	9755
@NP	H.E. staining	9774
@NP	those in the right column	9794
@NP	those	9794
@NP	the right column	9803
@NP	GFAP immunostaining	9824
@NP	tissue , repaired tissue and lesion cavity	9852
@NP	tissue	9852
@NP	tissue and lesion cavity	9869
@NP	the glial scars with sharp edge	9918
@NP	the glial scars	9918
@NP	sharp edge	9939
@NP	arrows	9969
@NP	the last two groups -LRB- D and E rows -RRB-	9980
@NP	the last two groups	9980
@NP	D and E rows	10001
@NP	D	10001
@NP	E rows	10007
@NP	development of repaired tissue	10016
@NP	development	10016
@NP	repaired tissue	10031
@NP	disappearance	10048
@NP	the lesion cavities	10065
@NP	integration of repaired tissue with spared tissue -LRB- D ′ , E ′ -RRB-	10086
@NP	integration	10086
@NP	repaired tissue with spared tissue -LRB- D ′ , E ′ -RRB-	10101
@NP	repaired tissue	10101
@NP	spared tissue -LRB- D ′ , E ′ -RRB-	10122
@NP	spared tissue	10122
@NP	D ′	10137
@NP	E ′	10141
@NP	disappearance of glial scar -LRB- D ″ , E ″ -RRB-	10150
@NP	disappearance	10150
@NP	glial scar -LRB- D ″ , E ″ -RRB-	10167
@NP	glial scar	10167
@NP	D ″	10179
@NP	E ″	10183
@NP	SCI	10215
@NP	spinal cord injury	10220
@NP	spinal cord	10220
@NP	injury	10232
@NP	SA : scar ablation	10240
@NP	SA	10240
@NP	scar ablation	10244
@NP	LP : LP transplantation	10259
@NP	LP	10259
@NP	LP transplantation	10263
@NP	OEC : OEC transplantation	10283
@NP	OEC	10283
@NP	OEC transplantation	10288
@NP	ST	10309
@NP	tissue	10320
@NP	DR	10328
@NP	dorsal root	10332
@NP	Scale bars	10345
@NP	0.5 mm -LRB- left column -RRB- , 50 μm -LRB- all others -RRB-	10357
@NP	0.5 mm	10357
@NP	left column	10364
@NP	50 μm -LRB- all others -RRB-	10378
@NP	50 μm	10378
@NP	all others	10385
@NP	Fig. 5 -- Quantitative analysis of tissue repair .	10399
@NP	Fig. 5	10399
@NP	Quantitative analysis of tissue repair	10408
@NP	Quantitative analysis	10408
@NP	tissue repair	10433
@NP	The percentages	10448
@NP	spared tissue	10467
@NP	tissue and lesion cavity	10491
@NP	the whole area of a cross section	10519
@NP	the whole area	10519
@NP	a cross section	10537
@NP	the injury epicenter in each group	10556
@NP	the injury epicenter	10556
@NP	each group	10580
@NP	± SEM	10606
@NP	Changes	10613
@NP	Groups SCI-6w and SCI-22w as well as between Group SCI-22w and Group SCI+SA	10629
@NP	Groups SCI-6w and SCI-22w	10629
@NP	between Group SCI-22w and Group SCI+SA	10666
@NP	Group SCI-22w and Group SCI+SA	10674
@NP	the developments of repaired tissue and the reduction of lesion cavities	10733
@NP	the developments	10733
@NP	repaired tissue and the reduction of lesion cavities	10753
@NP	repaired tissue	10753
@NP	the reduction of lesion cavities	10773
@NP	the reduction	10773
@NP	lesion cavities	10790
@NP	p	10841
@NP	0.01	10843
@NP	groups with transplantations	10852
@NP	groups	10852
@NP	transplantations	10864
@NP	the SCI-22w control group	10900
@NP	SCI	10927
@NP	spinal cord injury ; 6w/22w	10932
@NP	spinal cord injury	10932
@NP	6w/22w	10952
@NP	6 or 22 weeks	10960
@NP	SCI ; SA : scar ablation ; LP : LP transplantation ; OEC : OEC transplantation	10980
@NP	SCI	10980
@NP	SA	10985
@NP	scar ablation	10989
@NP	LP	11004
@NP	LP transplantation	11008
@NP	OEC	11028
@NP	OEC transplantation	11033
@NP	Fig. 7 -- Quantitative analysis of P0-positive myelination .	11055
@NP	Fig. 7	11055
@NP	Quantitative analysis of P0-positive myelination	11064
@NP	Quantitative analysis	11064
@NP	P0-positive myelination	11089
@NP	the cross sections	11117
@NP	the P0-positive myelin sheaths	11137
@NP	the repaired tissue , lesion cavity	11184
@NP	the repaired tissue	11184
@NP	lesion cavity	11205
@NP	tissue	11231
@NP	the injury epicenter	11241
@NP	The average number -LRB- mean ± SEM -RRB-	11263
@NP	The average number	11263
@NP	mean ± SEM	11283
@NP	P0-positive myelin sheaths and the comparison among groups	11297
@NP	P0-positive myelin sheaths	11297
@NP	the comparison among groups	11328
@NP	the comparison	11328
@NP	groups	11349
@NP	p < 0.05 ; ** : p < 0.01	11370
@NP	p	11370
@NP	0.05 ; ** : p <	11372
@NP	0.05	11372
@NP	p	11382
@NP	0.01	11384
@NP	SCI	11390
@NP	spinal cord injury	11395
@NP	spinal cord	11395
@NP	injury	11407
@NP	LP : LP transplantation	11415
@NP	LP	11415
@NP	LP transplantation	11419
@NP	OEC : OEC transplantation	11439
@NP	OEC	11439
@NP	OEC transplantation	11444
@NP	SA : scar ablation	11465
@NP	SA	11465
@NP	scar ablation	11469
@NP	the first two groups	11494
@NP	6 weeks or 22 weeks	11519
@NP	6 weeks	11519
@NP	22 weeks	11530
@NP	SCI	11545
@NP	other groups	11550
@NP	all 16 weeks after secondary surgeries , i.e. , 22 weeks after SCI	11567
@NP	all 16 weeks after secondary surgeries , i.e. ,	11567
@NP	all 16 weeks after secondary surgeries	11567
@NP	all 16 weeks	11567
@NP	secondary surgeries	11586
@NP	22 weeks	11613
@NP	SCI	11628
@NP	Fig. 6 -- P0-positive myelination .	11634
@NP	Fig. 6	11634
@NP	P0-positive myelination	11643
@NP	Representative photomicrographs	11668
@NP	P0 immunostaining	11703
@NP	the injury	11726
@NP	control group -LRB- A -RRB- and the full treatment group -LRB- B -RRB-	11743
@NP	control group -LRB- A -RRB-	11743
@NP	control group	11743
@NP	A	11758
@NP	the full treatment group -LRB- B -RRB-	11765
@NP	the full treatment group	11765
@NP	B	11791
@NP	the distribution of P0-positive myelin sheaths at the injury site	11805
@NP	the distribution	11805
@NP	P0-positive myelin sheaths at the injury site	11825
@NP	P0-positive myelin sheaths	11825
@NP	the injury site	11855
@NP	A ′ and B ′	11872
@NP	local magnifications of A and B	11886
@NP	local magnifications	11886
@NP	A and B	11910
@NP	The myelin sheaths	11933
@NP	dark brown in color	11964
@NP	dark brown	11964
@NP	color	11978
@NP	small circles or dots	11998
@NP	arrowheads in insert , which is local magnification of B ′	12021
@NP	arrowheads	12021
@NP	insert , which is local magnification of B ′	12035
@NP	insert	12035
@NP	local magnification of B ′	12052
@NP	local magnification	12052
@NP	B ′	12075
@NP	The P0-positive myelin sheaths	12080
@NP	the repaired tissue , lesion cavity	12131
@NP	the repaired tissue	12131
@NP	lesion cavity	12152
@NP	tissue	12185
@NP	the dorsal roots -LRB- DR -RRB- and ventral roots -LRB- VR -RRB-	12204
@NP	the dorsal roots	12204
@NP	DR	12222
@NP	ventral roots	12230
@NP	VR	12245
@NP	The average numbers of P0-positive myelin sheaths in individual groups	12250
@NP	The average numbers	12250
@NP	P0-positive myelin sheaths in individual groups	12273
@NP	P0-positive myelin sheaths	12273
@NP	individual groups	12303
@NP	Fig. 7	12338
@NP	SCI	12346
@NP	spinal cord injury	12351
@NP	spinal cord	12351
@NP	injury	12363
@NP	SA : scar ablation	12371
@NP	SA	12371
@NP	scar ablation	12375
@NP	LP : LP transplantation	12390
@NP	LP	12390
@NP	LP transplantation	12394
@NP	OEC : OEC transplantation	12414
@NP	OEC	12414
@NP	OEC transplantation	12419
@NP	Scale bars	12440
@NP	0.5 mm -LRB- A , B -RRB-	12452
@NP	A , B	12459
@NP	A	12459
@NP	B	12462
@NP	0.1 mm -LRB- A ′ , B ′ -RRB-	12466
@NP	A ′ , B ′	12473
@NP	A ′	12473
@NP	B ′	12477
@NP	20 μm -LRB- insert -RRB-	12482
@NP	insert	12489
@NP	Fig. 8 -- Locomotor outcome .	12499
@NP	Fig. 8	12499
@NP	Locomotor outcome	12508
@NP	Functional recovery after transplantation	12527
@NP	Functional recovery	12527
@NP	transplantation	12553
@NP	BBB open field scale and the BBB scores	12588
@NP	BBB open field scale	12588
@NP	the BBB scores	12613
@NP	± SEM	12633
@NP	different groups are shown	12644
@NP	different groups	12644
@NP	There	12672
@NP	no significant difference	12681
@NP	any two groups or self	12722
@NP	any two groups	12722
@NP	self	12740
@NP	treatments in any individual group -LRB- p > 0.05 -RRB-	12777
@NP	treatments	12777
@NP	any individual group -LRB- p > 0.05 -RRB-	12791
@NP	any individual group	12791
@NP	p > 0.05	12813
@NP	p	12813
@NP	> 0.05	12814
@NP	>	12814
@NP	0.05	12815
@NP	SCI	12822
@NP	spinal cord injury	12827
@NP	spinal cord	12827
@NP	injury	12839
@NP	SA : scar ablation	12847
@NP	SA	12847
@NP	scar ablation	12851
@NP	LP : LP transplantation	12866
@NP	LP	12866
@NP	LP transplantation	12870
@NP	OEC : OEC transplantation	12890
@NP	OEC	12890
@NP	OEC transplantation	12895
@NP	6/0w	12916
@NP	6 weeks after SCI	12922
@NP	6 weeks	12922
@NP	SCI	12936
@NP	the transplantation ; 22/16 : 22 weeks after SCI	12958
@NP	the transplantation ; 22/16	12958
@NP	the transplantation	12958
@NP	22/16	12979
@NP	22 weeks after SCI	12986
@NP	22 weeks	12986
@NP	SCI	13001
@NP	16 weeks after secondary surgeries	13011
@NP	16 weeks	13011
@NP	secondary surgeries	13026
@NP	2.1	13049
@NP	Confirmation of scar ablation and LP transplantation The glial scar	13054
@NP	Confirmation	13054
@NP	scar ablation and LP transplantation The glial scar	13070
@NP	scar ablation and LP transplantation	13070
@NP	The glial scar	13107
@NP	the inner edge	13137
@NP	the spared tissue	13155
@NP	of 2 or 3 layers of GFAP-positive cells	13185
@NP	of 2 or 3 layers	13185
@NP	GFAP-positive cells	13205
@NP	a smooth free surface	13230
@NP	the lesion cavity	13260
@NP	there	13283
@NP	no clear border between the glial scar	13292
@NP	no clear border	13292
@NP	the glial scar	13316
@NP	tissue -LRB- Fig. 2A and B ; Fig. 4A -RRB-	13342
@NP	tissue	13342
@NP	Fig. 2A and B ; Fig. 4A	13350
@NP	Fig. 2A and B	13350
@NP	Fig. 4A	13365
@NP	Eight minutes	13375
@NP	the lesion cavity	13415
@NP	the	13434
@NP	Bengal	13443
@NP	the cell body and processes of the superficial cells	13478
@NP	the cell body	13478
@NP	processes of the superficial cells	13496
@NP	processes	13496
@NP	the superficial cells	13509
@NP	the morphology	13536
@NP	astrocytes -LRB- Fig. 2C -RRB- , which constitute the scar tissue	13554
@NP	astrocytes -LRB- Fig. 2C -RRB-	13554
@NP	astrocytes	13554
@NP	Fig. 2C	13566
@NP	the scar tissue	13593
@NP	Collateral cells within the deeper portion of the spared tissue	13610
@NP	Collateral cells	13610
@NP	the deeper portion of the spared tissue	13634
@NP	the deeper portion	13634
@NP	the spared tissue	13656
@NP	the	13694
@NP	illumination	13709
@NP	Bengal-stained cells of the glial scar	13728
@NP	Bengal-stained cells	13728
@NP	the glial scar	13752
@NP	phototoxicity	13782
@NP	the separation or disruption	13810
@NP	damaged glial scar from the spared tissue -LRB- Fig. 2D -RRB-	13842
@NP	damaged glial scar	13842
@NP	the spared tissue -LRB- Fig. 2D -RRB-	13866
@NP	the spared tissue	13866
@NP	Fig. 2D	13885
@NP	The transplanted LP	13895
@NP	the lesion cavity close	13948
@NP	the spared tissue -LRB- Fig. 2D -RRB-	13975
@NP	the spared tissue	13975
@NP	Fig. 2D	13994
@NP	2.2	14004
@NP	Survival	14009
@NP	transplanted GFP-LP and relationwith axons	14021
@NP	Eight weeks	14064
@NP	scar ablation and transplantation	14082
@NP	GFP-LP into the lesion cavity , the GFP-positive cells	14119
@NP	GFP-LP	14119
@NP	the lesion cavity , the GFP-positive cells	14131
@NP	the lesion cavity	14131
@NP	the GFP-positive cells	14150
@NP	the injury epicenter	14194
@NP	They	14216
@NP	the lesion cavity	14247
@NP	the host spared tissue which was labeled by the GFAP marker -LRB- Fig. 3A -RRB-	14283
@NP	the host	14283
@NP	tissue which was labeled by the GFAP marker -LRB- Fig. 3A -RRB-	14299
@NP	tissue	14299
@NP	the GFAP marker -LRB- Fig. 3A -RRB-	14327
@NP	the GFAP marker	14327
@NP	Fig. 3A	14344
@NP	addition	14357
@NP	the orientation of GFP-positive cells	14367
@NP	the orientation	14367
@NP	GFP-positive cells	14386
@NP	a nonparallel pattern in relation	14424
@NP	a nonparallel pattern	14424
@NP	relation	14449
@NP	the longitudinal axis of the spinal cord	14461
@NP	the longitudinal axis	14461
@NP	the spinal cord	14486
@NP	the axons	14506
@NP	the GFP-positive cells -LRB- Fig. 3B -RRB-	14556
@NP	the GFP-positive cells	14556
@NP	Fig. 3B	14580
@NP	The observation	14590
@NP	the survival of cells	14616
@NP	the survival	14616
@NP	cells	14632
@NP	transplanted LP	14643
@NP	other recent observation of the survival of transplanted OECs	14676
@NP	other recent observation	14676
@NP	the survival of transplanted OECs	14704
@NP	the survival	14704
@NP	transplanted OECs	14720
@NP	a lesion cavity of rat contused spinal cord -LRB- Li et al. , 2010 -RRB-	14743
@NP	a lesion cavity	14743
@NP	rat contused spinal cord -LRB- Li et al. , 2010 -RRB-	14762
@NP	rat	14762
@NP	spinal cord -LRB- Li et al. , 2010 -RRB-	14775
@NP	spinal cord	14775
@NP	Li	14788
@NP	et al. , 2010	14791
@NP	et al.	14791
@NP	2010	14799
@NP	2.3	14806
@NP	Tissue	14811
@NP	scar ablation and transplantation Similar	14834
@NP	scar ablation	14834
@NP	transplantation Similar	14852
@NP	the results	14879
@NP	6 weeks	14896
@NP	contusion injury	14910
@NP	Fig. 2A and B	14928
@NP	Fig. 2A	14928
@NP	B	14940
@NP	the injury control animals 22 weeks after SCI a clear lesion cavity	14947
@NP	the injury control animals	14947
@NP	22 weeks	14974
@NP	SCI	14989
@NP	a clear lesion cavity	14993
@NP	the injury site	15036
@NP	the spared tissue by the glial scar	15075
@NP	the spared tissue	15075
@NP	the glial scar	15096
@NP	The morphology	15112
@NP	glial scar and the endogenous repaired tissue in size at the injury epicenter	15130
@NP	glial scar	15130
@NP	the endogenous repaired tissue in size at the injury epicenter	15145
@NP	the endogenous	15145
@NP	tissue in size	15169
@NP	tissue	15169
@NP	size	15179
@NP	the injury epicenter	15187
@NP	significant change -LRB- Fig. 4A , A ′ , and A ″ ; Fig. 5 -RRB-	15222
@NP	significant change	15222
@NP	Fig. 4A , A ′ , and A ″ ; Fig. 5	15242
@NP	Fig. 4A	15242
@NP	A ′	15251
@NP	A ″ ; Fig. 5	15259
@NP	A ″	15259
@NP	Fig. 5	15263
@NP	the contrary	15275
@NP	the animals	15292
@NP	scar ablation	15318
@NP	conjunction	15335
@NP	transplantation of either LP or LP plus OEC	15352
@NP	transplantation	15352
@NP	either LP or LP	15371
@NP	LP	15378
@NP	LP	15384
@NP	OEC	15392
@NP	the repaired tissue	15397
@NP	the lesion cavity	15446
@NP	marked reduction	15478
@NP	even disappearance of the lesion cavity	15495
@NP	even disappearance	15495
@NP	the lesion cavity	15517
@NP	fact	15539
@NP	transplanted LP	15545
@NP	the repaired tissue at the injury site	15606
@NP	the repaired tissue	15606
@NP	the injury site	15629
@NP	numerous Schwann	15652
@NP	cell-like , young cells	15669
@NP	the transplanted tissue or cells	15723
@NP	the transplanted tissue	15723
@NP	cells	15750
@NP	a part of the repaired tissue	15801
@NP	a part	15801
@NP	the repaired tissue	15811
@NP	no apparent border	15850
@NP	the repaired tissue	15890
@NP	tissue	15921
@NP	the repaired tissue	15945
@NP	the spared tissue	15995
@NP	addition	16017
@NP	the typical glial scar detected by GFAP immunostaining	16027
@NP	the typical glial scar	16027
@NP	GFAP immunostaining	16062
@NP	Fig. 4D -- E ″	16097
@NP	Fig. 4D	16097
@NP	E ″	16105
@NP	the injury control group	16120
@NP	the group of LP transplantation	16151
@NP	the group	16151
@NP	LP transplantation	16164
@NP	scar ablation	16191
@NP	this further	16206
@NP	the merging of two different tissues	16228
@NP	the merging	16228
@NP	two different tissues	16243
@NP	animals	16269
@NP	LP or LP/OEC transplantation	16287
@NP	scar ablation	16324
@NP	the repaired tissue	16339
@NP	16 weeks	16381
@NP	transplantation	16396
@NP	it	16417
@NP	the spared tissue	16438
@NP	the glial scar	16459
@NP	the lesion cavity -LRB- Fig. 4B , B ′ , and B ″ ; Fig. 5 -RRB-	16478
@NP	the lesion cavity	16478
@NP	Fig. 4B , B ′ , and B ″ ; Fig. 5	16497
@NP	Fig. 4B	16497
@NP	B ′	16506
@NP	B ″ ; Fig. 5	16514
@NP	B ″	16514
@NP	Fig. 5	16518
@NP	Quantitative analysis	16527
@NP	the changes of repaired tissue and lesion cavity in size	16555
@NP	the changes	16555
@NP	repaired tissue and lesion cavity in size	16570
@NP	repaired tissue and lesion cavity	16570
@NP	size	16607
@NP	Fig. 5	16624
@NP	There	16632
@NP	no prominent changes	16642
@NP	tissue and lesion cavity in size in a long period of time	16673
@NP	tissue and lesion cavity	16673
@NP	size in a long period of time	16701
@NP	size	16701
@NP	a long period of time	16709
@NP	a long period	16709
@NP	time	16726
@NP	injury	16737
@NP	rats	16747
@NP	no treatment -LRB- SCI-6w vs.	16760
@NP	treatment -LRB- SCI-6w vs.	16763
@NP	treatment	16763
@NP	SCI-6w vs.	16774
@NP	SCI-6w	16774
@NP	vs.	16781
@NP	SCI-22w	16785
@NP	the expansion of repaired tissue and the reduction of lesion cavities in size	16804
@NP	the expansion	16804
@NP	repaired tissue and the reduction of lesion cavities in size	16821
@NP	repaired tissue	16821
@NP	the reduction of lesion cavities in size	16841
@NP	the reduction	16841
@NP	lesion cavities in size	16858
@NP	lesion cavities	16858
@NP	size	16877
@NP	p < 0.01	16913
@NP	p	16913
@NP	< 0.01	16914
@NP	<	16914
@NP	0.01	16915
@NP	groups with transplantations	16924
@NP	groups	16924
@NP	transplantations	16936
@NP	the injury	16972
@NP	only control group -LRB- SCI-22w -RRB-	16983
@NP	only control group	16983
@NP	SCI-22w	17003
@NP	2.4	17013
@NP	Prevention of scar reformation by transplantation	17018
@NP	Prevention	17018
@NP	scar reformation by transplantation	17032
@NP	scar reformation	17032
@NP	transplantation	17052
@NP	scar ablation	17074
@NP	LP or OEC transplantation	17096
@NP	the endogenous	17123
@NP	tissue and lesion cavity	17147
@NP	obvious change	17187
@NP	size	17205
@NP	Fig. 5	17211
@NP	the number	17220
@NP	P0-positive myelin sheaths	17234
@NP	Fig. 7	17262
@NP	the BBB scores	17274
@NP	Fig. 8	17290
@NP	those seen 6 weeks after injury	17350
@NP	those	17350
@NP	6 weeks	17361
@NP	injury	17375
@NP	the surviving astrocytes at the deeper portion of the glial scar	17392
@NP	the surviving astrocytes	17392
@NP	the deeper portion of the glial scar	17420
@NP	the deeper portion	17420
@NP	the glial scar	17442
@NP	the inner edge of the spared tissue	17485
@NP	the inner edge	17485
@NP	the spared tissue	17503
@NP	the reformation of the glial scar -LRB- Fig. 4C ′ -RRB-	17541
@NP	the reformation of the glial scar	17541
@NP	the reformation	17541
@NP	the glial scar	17560
@NP	Fig. 4C ′	17576
@NP	Similar	17587
@NP	the original glial scar -LRB- Fig. 2A and B -RRB- , the newly formed glial scar	17598
@NP	the original glial scar -LRB- Fig. 2A and B -RRB-	17598
@NP	the original glial scar	17598
@NP	Fig. 2A and B	17623
@NP	Fig. 2A	17623
@NP	B	17635
@NP	the newly formed glial scar	17639
@NP	the lesion cavity	17673
@NP	strong GFAP-immunoreactivity	17701
@NP	the spared tissue -LRB- Fig. 4C ″ -RRB-	17741
@NP	the spared tissue	17741
@NP	Fig. 4C ″	17760
@NP	Fig.	17760
@NP	4C ″	17765
@NP	The glial scar	17771
@NP	dense GFAP immunostaining 22 weeks	17812
@NP	dense GFAP immunostaining	17812
@NP	22 weeks	17838
@NP	contusion injury -LRB- Fig. 4A ″ -RRB- , similar to what was observed before	17853
@NP	contusion injury -LRB- Fig. 4A ″ -RRB-	17853
@NP	contusion injury	17853
@NP	Fig. 4A ″	17871
@NP	rats with LP transplantation but no scar ablation	17922
@NP	rats	17922
@NP	LP transplantation but no scar ablation	17932
@NP	LP transplantation	17932
@NP	no scar ablation	17955
@NP	the glial scar	17973
@NP	prominent modification	18001
@NP	16 weeks	18024
@NP	transplantation	18039
@NP	Fig. 4B ″	18056
@NP	Fig.	18056
@NP	4B ″	18061
@NP	the animals with scar ablation and LP or LP plus OEC transplantation	18078
@NP	the animals with scar ablation and LP	18078
@NP	the animals	18078
@NP	scar ablation and LP	18095
@NP	LP plus OEC transplantation	18119
@NP	LP	18119
@NP	OEC transplantation	18127
@NP	the glial scar	18148
@NP	proximity	18166
@NP	it	18185
@NP	its characteristic sharp , densely-stained GFAP profile	18234
@NP	a dentate	18310
@NP	irregular or reticular appearance	18321
@NP	GFAP immunoreactivity -LRB- Fig. 4D ″ and E ″ -RRB-	18358
@NP	GFAP immunoreactivity	18358
@NP	Fig. 4D ″ and E ″	18381
@NP	Fig. 4D ″	18381
@NP	E ″	18394
@NP	the glial scar	18413
@NP	2.5	18446
@NP	Increase in P0-positive myelination after combination treatments	18451
@NP	Increase	18451
@NP	P0-positive myelination after combination treatments	18463
@NP	P0-positive myelination	18463
@NP	combination treatments	18493
@NP	our previous observation , Schwann cells and Schwann cell-formed myelin sheaths	18529
@NP	our previous observation	18529
@NP	Schwann cells	18555
@NP	Schwann cell-formed myelin sheaths	18573
@NP	the endogenous repaired tissue	18627
@NP	connective tissue scar	18677
@NP	two weeks	18701
@NP	contusion injury -LRB- Zhang et al. , 2005 -RRB-	18717
@NP	contusion injury	18717
@NP	Zhang	18735
@NP	et al. , 2005	18741
@NP	et al.	18741
@NP	2005	18749
@NP	Some of the Schwann cells	18756
@NP	Some	18756
@NP	the Schwann cells	18764
@NP	the repaired tissue to the spared tissue	18799
@NP	the repaired tissue	18799
@NP	the spared tissue	18822
@NP	the trabeculae between the spared tissue and the repaired tissue	18857
@NP	the trabeculae	18857
@NP	the spared tissue and the repaired tissue	18880
@NP	the spared tissue	18880
@NP	the repaired tissue	18902
@NP	some	18926
@NP	the ventral root	18950
@NP	the axons	18981
@NP	the spared tissue of ventral portion of the cord	18994
@NP	the spared tissue	18994
@NP	ventral portion of the cord	19015
@NP	ventral portion	19015
@NP	the cord	19034
@NP	this study	19047
@NP	P0-positive myelination possibly formed by the host Schwann cells	19059
@NP	P0-positive myelination	19059
@NP	the host Schwann cells	19102
@NP	the repaired tissue , lesion cavity	19139
@NP	the repaired tissue	19139
@NP	lesion cavity	19160
@NP	tissue -LRB- Fig. 6 -RRB-	19186
@NP	tissue	19186
@NP	Fig. 6	19194
@NP	These myelinated fibers	19203
@NP	regenerating axons	19239
@NP	axons	19274
@NP	P0 - positive myelin sheaths in the repaired tissue	19281
@NP	P0	19281
@NP	positive myelin sheaths in the repaired tissue	19285
@NP	positive myelin sheaths	19285
@NP	the repaired tissue	19312
@NP	both	19344
@NP	axons	19374
@NP	Quantitative analysis of P0-positive myelination	19381
@NP	Quantitative analysis	19381
@NP	P0-positive myelination	19406
@NP	Fig. 7	19442
@NP	injury alone control rats	19453
@NP	injury	19453
@NP	alone control rats	19460
@NP	the number of P0-positive myelin sheaths	19479
@NP	the number	19479
@NP	P0-positive myelin sheaths	19493
@NP	a significant change	19533
@NP	the last 16 weeks -LRB- SCI 22w : 1750 ± 254 , n = 6 -RRB-	19557
@NP	the last 16 weeks	19557
@NP	SCI 22w : 1750 ± 254 , n = 6	19576
@NP	SCI 22w	19576
@NP	1750 ± 254 , n = 6	19585
@NP	1750 ±	19585
@NP	254 , n = 6	19590
@NP	254	19590
@NP	n = 6	19595
@NP	n	19595
@NP	6	19597
@NP	that found 6 weeks after injury -LRB- SCI 6w : 1966 ± 433 , n = 5 -RRB-	19614
@NP	that	19614
@NP	6 weeks	19625
@NP	injury	19639
@NP	SCI 6w : 1966 ± 433 , n = 5	19647
@NP	SCI 6w	19647
@NP	1966 ± 433 , n = 5	19655
@NP	1966 ± 433 , n	19655
@NP	5	19667
@NP	The number of P0-positive myelin sheaths	19671
@NP	The number	19671
@NP	P0-positive myelin sheaths	19685
@NP	rats with LP -LRB- SCI+LP : 2268 ± 385 , n = 4 -RRB-	19734
@NP	rats	19734
@NP	LP -LRB- SCI+LP : 2268 ± 385 , n = 4 -RRB-	19744
@NP	LP	19744
@NP	SCI+LP : 2268 ± 385 , n = 4	19748
@NP	SCI+LP	19748
@NP	2268 ± 385 , n = 4	19756
@NP	2268 ± 385 , n	19756
@NP	4	19768
@NP	LP plus OEC -LRB- SCI+LP+OEC : 2584 ± 198 , n = 5 -RRB-	19774
@NP	LP	19774
@NP	OEC -LRB- SCI+LP+OEC : 2584 ± 198 , n = 5 -RRB-	19782
@NP	OEC	19782
@NP	SCI+LP+OEC : 2584 ± 198 , n = 5	19787
@NP	SCI+LP+OEC	19787
@NP	2584 ± 198 , n = 5	19799
@NP	2584 ± 198	19799
@NP	n = 5	19810
@NP	n	19810
@NP	5	19812
@NP	scar ablation	19839
@NP	the difference	19863
@NP	the SCI control animals	19931
@NP	Rats subjected to scar ablation	19956
@NP	Rats	19956
@NP	scar ablation	19974
@NP	an increase	20007
@NP	number of P0-positive myelin sheaths -LRB- SCI+SA : 1759 ± 215 , n = 6 -RRB-	20022
@NP	number	20022
@NP	P0-positive myelin sheaths -LRB- SCI+SA : 1759 ± 215 , n = 6 -RRB-	20032
@NP	P0-positive myelin sheaths	20032
@NP	SCI+SA : 1759 ± 215 , n = 6	20060
@NP	SCI+SA	20060
@NP	1759 ± 215 , n = 6	20068
@NP	1759 ± 215 , n	20068
@NP	6	20080
@NP	injury	20102
@NP	alone control rats	20109
@NP	The group	20129
@NP	scar ablation and LP transplantation showedmore P0-positivemyelin sheaths	20153
@NP	SCI+SA+LP : 3043 ± 404 , n = 8	20228
@NP	SCI+SA+LP	20228
@NP	3043 ± 404 , n = 8	20239
@NP	3043 ± 404 , n	20239
@NP	8	20251
@NP	a significant difference when	20259
@NP	a significant difference	20259
@NP	the control animals	20303
@NP	A further increase in the number of P0-positive myelin sheaths	20324
@NP	A further increase	20324
@NP	the number of P0-positive myelin sheaths	20346
@NP	the number	20346
@NP	P0-positive myelin sheaths	20360
@NP	the group	20403
@NP	scar ablation andtransplantation	20423
@NP	both LP and OECs -LRB- SCI+SA+LP+OEC : 4001 ± 569 , n = 7 -RRB-	20459
@NP	LP	20464
@NP	OECs -LRB- SCI+SA+LP+OEC : 4001 ± 569 , n = 7 -RRB-	20471
@NP	OECs	20471
@NP	SCI+SA+LP+OEC : 4001 ± 569 , n = 7	20477
@NP	SCI+SA+LP+OEC	20477
@NP	4001 ± 569 , n = 7	20492
@NP	4001 ± 569 , n	20492
@NP	7	20504
@NP	2.6	20508
@NP	Locomotor outcome of functional recovery Locomotor functional recovery after SCI	20513
@NP	Locomotor outcome	20513
@NP	functional recovery Locomotor functional recovery	20534
@NP	SCI	20590
@NP	the indicated interventions	20598
@NP	the BBB open field scale -LRB- Basso et al. , 1995 ; 1996 -RRB-	20647
@NP	the BBB open field scale	20647
@NP	Basso	20673
@NP	et al. , 1995 ; 1996	20679
@NP	et al.	20679
@NP	1995 ; 1996	20687
@NP	Control animals receiving contusion injury only	20700
@NP	Control animals	20700
@NP	contusion injury	20726
@NP	a functional level	20762
@NP	the final 16 weeks	20824
@NP	observation -LRB- SCI control : 9.35 ± 0.21 to 9.45 ± 0.31 , n = 10 -RRB-	20846
@NP	observation	20846
@NP	SCI control : 9.35 ± 0.21 to 9.45 ± 0.31 , n = 10	20859
@NP	SCI control	20859
@NP	9.35 ± 0.21 to 9.45 ± 0.31 , n = 10	20872
@NP	9.35 ± 0.21 to 9.45 ± 0.31	20872
@NP	9.35	20872
@NP	± 0.21 to 9.45 ± 0.31	20876
@NP	n = 10	20896
@NP	n	20896
@NP	10	20898
@NP	Fig. 8	20903
@NP	Animals receiving LP transplantation	20912
@NP	Animals	20912
@NP	LP transplantation	20930
@NP	BBB scores that started off at 9.27 ± 0.27 before transplantation	20977
@NP	BBB scores	20977
@NP	9.27 ± 0.27	21008
@NP	transplantation	21025
@NP	9.73 ± 0	21054
@NP	36 sixteen weeks after transplantation -LRB- n = 11 -RRB- .	21062
@NP	36	21062
@NP	sixteen weeks	21065
@NP	transplantation -LRB- n = 11 -RRB-	21085
@NP	transplantation	21085
@NP	n	21102
@NP	11	21104
@NP	Animals receiving LP/OEC transplantation without scar ablation	21109
@NP	Animals	21109
@NP	LP/OEC transplantation	21127
@NP	scar ablation	21158
@NP	their BBB scores	21185
@NP	the final 16 weeks of observation	21217
@NP	the final 16 weeks	21217
@NP	observation	21239
@NP	9.30 ± 0.40 to 9.30 ± 0.37 , n = 10	21252
@NP	9.30	21252
@NP	± 0.40 to 9.30 ± 0.37 , n = 10	21256
@NP	± 0.40 to 9.30 ± 0.37	21256
@NP	n = 10	21277
@NP	n	21277
@NP	10	21279
@NP	BBB scores from animals with scar ablation but not transplantation	21284
@NP	BBB scores	21284
@NP	animals with scar ablation but not transplantation	21300
@NP	animals with scar ablation	21300
@NP	animals	21300
@NP	scar ablation	21313
@NP	transplantation	21335
@NP	no change after scar ablation -LRB- 9.22 ± 0.40 to 9.22 ± 0.40 , n = 9 -RRB-	21358
@NP	no change after scar ablation	21358
@NP	scar	21374
@NP	9.22 ± 0.40 to 9.22 ± 0.40 , n	21389
@NP	9.22 ± 0.40 to 9.22 ± 0.40	21389
@NP	9.22	21389
@NP	± 0.40 to 9.22 ± 0.40	21393
@NP	n	21413
@NP	9	21415
@NP	Animals receiving both scar ablation and LP transplantation	21419
@NP	Animals	21419
@NP	both scar ablation and LP transplantation	21437
@NP	scar ablation	21442
@NP	LP transplantation	21460
@NP	a change from 9.44 ± 0.33 before transplantation	21492
@NP	9.44 ± 0.33 before	21506
@NP	9.44 ±	21506
@NP	0.33	21511
@NP	9.88 ± 0.35	21542
@NP	sixteen weeks	21552
@NP	transplantation	21572
@NP	n = 8	21589
@NP	n	21589
@NP	= 8	21590
@NP	animals receiving scar ablation and LP/OEC transplantation -LRB- n = 11 -RRB-	21601
@NP	animals	21601
@NP	scar ablation and LP/OEC transplantation -LRB- n = 11 -RRB-	21619
@NP	scar ablation and LP/OEC transplantation	21619
@NP	n	21661
@NP	11	21663
@NP	BBB scores changed from 9.27 ± 0.30 before transplantation to 9.45 ± 0.34	21671
@NP	BBB scores	21671
@NP	9.27 ± 0.30	21695
@NP	transplantation	21713
@NP	9.45 ± 0.34	21732
@NP	There	21743
@NP	no	21753
@NP	significant difference	21762
@NP	any two groups or any individual group	21800
@NP	any two groups	21800
@NP	any individual group	21818
@NP	transplantation -LRB- p > 0.05 -RRB-	21856
@NP	transplantation	21856
@NP	p > 0.05	21873
@NP	p	21873
@NP	> 0.05	21874
@NP	>	21874
@NP	0.05	21875
@NP	Discussion The most important finding from this study	21885
@NP	Discussion The most important finding	21885
@NP	Discussion	21885
@NP	The most important finding	21896
@NP	this study	21928
@NP	the first time	21952
@NP	histological repair of damaged cord tissue	21968
@NP	histological repair	21968
@NP	damaged cord tissue	21991
@NP	a combination of treatments	22030
@NP	a combination	22030
@NP	treatments	22047
@NP	scar ablation and LP/OEC transplantation	22063
@NP	scar ablation	22063
@NP	LP/OEC transplantation	22081
@NP	the lesion cavity in chronically contused rat spinal cord	22109
@NP	the lesion cavity	22109
@NP	chronically contused rat spinal cord	22130
@NP	This tissue repair or anatomical recovery	22168
@NP	This tissue repair	22168
@NP	anatomical recovery	22190
@NP	the prominent expansion	22230
@NP	endogenous	22257
@NP	tissue	22277
@NP	obvious reduction even disappearance of the lesion cavity	22285
@NP	obvious reduction	22285
@NP	even disappearance of the lesion cavity	22303
@NP	even disappearance	22303
@NP	the lesion cavity	22325
@NP	the integration of repaired tissue with spared tissue	22348
@NP	the integration	22348
@NP	repaired tissue with spared tissue	22367
@NP	repaired tissue	22367
@NP	spared tissue	22388
@NP	The tissue repair	22403
@NP	a beneficial condition	22430
@NP	the P0-positive myelination	22457
@NP	ablated glial scar	22508
@NP	Our findings	22543
@NP	removal of an existing glial scar	22573
@NP	removal	22573
@NP	an existing glial scar	22584
@NP	the tissue repair	22624
@NP	Endogenous tissue repair	22643
@NP	place	22674
@NP	contusion injury	22686
@NP	the dorsal part	22719
@NP	the cord	22738
@NP	the injury epicenter -LRB- Beattie et al. , 1997 ; Zhang et al. , 2011 -RRB-	22750
@NP	the injury epicenter	22750
@NP	Beattie	22772
@NP	et al. , 1997 ; Zhang et al. , 2011	22780
@NP	et al.	22780
@NP	1997 ; Zhang et al.	22788
@NP	1997	22788
@NP	Zhang et al.	22794
@NP	Zhang	22794
@NP	et al.	22800
@NP	2011	22808
@NP	contusion injury	22840
@NP	a great number of reactive fibroblasts	22858
@NP	a great number	22858
@NP	reactive fibroblasts	22876
@NP	the lesion cavity	22904
@NP	the dorsal pia mater	22927
@NP	the same time	22952
@NP	numerous Schwann cells	22967
@NP	the injury epicenter	23008
@NP	the dorsal roots	23034
@NP	This	23052
@NP	the initial , endogenous repaired tissue	23060
@NP	these two cell types	23123
@NP	novel blood vessels	23154
@NP	collagen fibers	23175
@NP	regenerating axons myelinated or ensheathed by Schwann cells	23195
@NP	regenerating axons	23195
@NP	Schwann cells	23242
@NP	The endogenous repaired tissue	23257
@NP	three zones : fibrotic , cellular and axonal	23308
@NP	three zones	23308
@NP	The fibrotic zone	23352
@NP	fibroblasts	23398
@NP	collagen fibers	23411
@NP	newly formed blood vessels	23432
@NP	Schwann cells	23460
@NP	axons	23488
@NP	The cellular zone	23495
@NP	densely compacted Schwann cells and some regenerating axons	23528
@NP	densely compacted Schwann cells	23528
@NP	some regenerating axons	23564
@NP	the earlier stage of tissue repair	23592
@NP	the earlier stage	23592
@NP	tissue repair	23613
@NP	the cellular zone	23627
@NP	a clear U-shaped shell	23663
@NP	the fibrotic zone	23698
@NP	it	23721
@NP	size	23755
@NP	time or following intervention treatments	23765
@NP	time	23765
@NP	following intervention treatments	23773
@NP	The axonal zone	23808
@NP	regenerating axons	23843
@NP	P0-positive myelin sheaths -LRB- Zhang et al. , 2011 -RRB-	23866
@NP	P0-positive myelin sheaths	23866
@NP	Zhang	23894
@NP	et al. , 2011	23900
@NP	et al.	23900
@NP	2011	23908
@NP	Histological evaluation and quantitative data	23915
@NP	repaired tissue in the present study	23964
@NP	repaired tissue	23964
@NP	the present study	23983
@NP	intervention treatment	24031
@NP	endogenous , spontaneous repair processes	24055
@NP	spinal cord injury	24130
@NP	Beattie	24150
@NP	et al. , 1997	24158
@NP	et al.	24158
@NP	1997	24166
@NP	Belegu et al. , 2007	24172
@NP	Belegu	24172
@NP	et al. , 2007	24179
@NP	et al.	24179
@NP	2007	24187
@NP	Brook et al. , 2000	24193
@NP	Brook	24193
@NP	et al. , 2000	24199
@NP	et al.	24199
@NP	2000	24207
@NP	Inoue et al. , 1998	24213
@NP	Inoue	24213
@NP	et al. , 1998	24219
@NP	et al.	24219
@NP	1998	24227
@NP	von Euler et al. , 2002	24233
@NP	von Euler	24233
@NP	et al. , 2002	24243
@NP	et al.	24243
@NP	2002	24251
@NP	the repaired tissue	24266
@NP	scar ablation and LP/OEC transplantation	24319
@NP	scar ablation	24319
@NP	LP/OEC transplantation	24337
@NP	more and more studies	24371
@NP	the OECs	24410
@NP	nerve growth factors	24433
@NP	the host Schwann cells	24465
@NP	the injury site	24502
@NP	the tissue	24540
@NP	Au et al. , 2007 ; Boyd et al. , 2005 ; Cao et al. , 2007 ; Ramer et al. , 2004	24562
@NP	Au	24562
@NP	et al. , 2007 ; Boyd et al. , 2005 ; Cao et al. , 2007 ; Ramer et al. , 2004	24565
@NP	et al. , 2007	24565
@NP	et al.	24565
@NP	2007	24573
@NP	Boyd et al. , 2005	24579
@NP	Boyd	24579
@NP	et al. , 2005	24584
@NP	et al.	24584
@NP	2005	24592
@NP	Cao et al. , 2007	24598
@NP	Cao	24598
@NP	et al. , 2007	24602
@NP	et al.	24602
@NP	2007	24610
@NP	Ramer et al. , 2004	24616
@NP	Ramer	24616
@NP	et al. , 2004	24622
@NP	et al.	24622
@NP	2004	24630
@NP	OECs	24637
@NP	Schwann cell-mediated anatomical and functional repair	24659
@NP	NPS injury	24720
@NP	adult rats -LRB- You et al. , 2010 -RRB-	24734
@NP	adult rats	24734
@NP	You	24746
@NP	et al. , 2010	24750
@NP	et al.	24750
@NP	2010	24758
@NP	Our observation in the present study	24765
@NP	Our observation	24765
@NP	the present study	24784
@NP	the elements which construct the endogenous repaired tissue at the early stage	24814
@NP	the elements	24814
@NP	the endogenous repaired tissue at the early stage	24843
@NP	the endogenous	24843
@NP	tissue	24867
@NP	the early stage	24877
@NP	the end of the experiment -LRB- 22 weeks after injury -RRB-	24921
@NP	the end	24921
@NP	the experiment -LRB- 22 weeks after injury -RRB-	24932
@NP	the experiment	24932
@NP	22 weeks after injury	24948
@NP	22 weeks	24948
@NP	injury	24963
@NP	the repaired tissue	24981
@NP	space of the lesion cavity	25028
@NP	space	25028
@NP	the lesion cavity	25037
@NP	combination treatments	25061
@NP	the transplanted OECs	25101
@NP	more Schwann cells	25163
@NP	the injury site	25219
@NP	the tissue repair	25267
@NP	one of the characteristic features of tissue repair	25300
@NP	one	25300
@NP	the characteristic features of tissue repair	25307
@NP	the characteristic features	25307
@NP	tissue repair	25338
@NP	the integration	25355
@NP	repaired tissue with the spared tissue -LRB- Zhang et al. , 2011 -RRB-	25374
@NP	repaired tissue	25374
@NP	the spared tissue -LRB- Zhang et al. , 2011 -RRB-	25395
@NP	the spared tissue	25395
@NP	Zhang	25414
@NP	et al. , 2011	25420
@NP	et al.	25420
@NP	2011	25428
@NP	intervention treatment	25452
@NP	spontaneous repair processes	25476
@NP	a number of factors including glial scarring -LRB- Webber et al. , 2007 -RRB-	25523
@NP	a number	25523
@NP	factors including glial scarring -LRB- Webber et al. , 2007 -RRB-	25535
@NP	factors	25535
@NP	glial scarring -LRB- Webber et al. , 2007 -RRB-	25553
@NP	glial scarring	25553
@NP	Webber	25569
@NP	et al. , 2007	25576
@NP	et al.	25576
@NP	2007	25584
@NP	Data from the present study	25591
@NP	Data	25591
@NP	the present study	25601
@NP	scar ablation	25639
@NP	tissue promoted by the LP/OEC transplantation	25672
@NP	tissue	25672
@NP	the LP/OEC transplantation	25691
@NP	the spared tissue , leaving obvious space between repaired tissue	25747
@NP	the spared tissue	25747
@NP	obvious space between repaired tissue	25774
@NP	obvious space	25774
@NP	repaired tissue	25796
@NP	tissue	25823
@NP	the presence of glial scar	25837
@NP	the presence	25837
@NP	glial scar	25853
@NP	the tissue integration	25880
@NP	It	25904
@NP	a scar ablation	25938
@NP	human fetal spinal cord transplants	25954
@NP	chronic contusion lesions of rat spinal cord	25995
@NP	chronic contusion lesions	25995
@NP	rat spinal cord	26024
@NP	welldefined tissue masses	26054
@NP	the surrounding host tissue	26116
@NP	heavy GFAP immunoreactivity	26149
@NP	a modest degree of host -- graft integration two months	26181
@NP	a modest degree of host	26181
@NP	a modest degree	26181
@NP	host	26200
@NP	graft integration two months	26205
@NP	graft integration	26205
@NP	two months	26223
@NP	transplantation -LRB- Giovanini et al. , 1997 -RRB-	26240
@NP	transplantation	26240
@NP	Giovanini	26257
@NP	et al. , 1997	26267
@NP	et al.	26267
@NP	1997	26275
@NP	Our present observations	26282
@NP	those reported results	26327
@NP	reliable evidence	26362
@NP	prior removal of an existing glial scar	26385
@NP	prior removal	26385
@NP	an existing glial scar	26402
@NP	tissue repair	26442
@NP	cell or tissue transplantation -LRB- Geller and Fawcett , 2002 -RRB-	26459
@NP	cell or tissue transplantation	26459
@NP	Geller and Fawcett	26491
@NP	2002	26511
@NP	glial scar	26543
@NP	two weeks	26560
@NP	contusion injury	26576
@NP	gliosis	26642
@NP	the typical glial scar with a smooth , free surface facing the lesion cavity ,	26651
@NP	the typical glial scar	26651
@NP	a smooth , free surface facing the lesion cavity	26679
@NP	a smooth , free surface	26679
@NP	the lesion cavity	26709
@NP	2 or 3 layers	26740
@NP	reactive astrocytes	26757
@NP	the inner edge of the spared tissue and walls	26784
@NP	the inner edge	26784
@NP	the spared tissue and walls	26802
@NP	the spared tissue	26802
@NP	walls	26824
@NP	the lesion cavity	26834
@NP	further damage of the cord tissue	26863
@NP	further damage	26863
@NP	the cord tissue	26881
@NP	Barrett	26898
@NP	et al. , 1981 ; Reier et al. , 1989 ; Zhang et al. , 2005 ; Zhang et al. , 2007	26906
@NP	et al. , 1981	26906
@NP	et al.	26906
@NP	1981	26914
@NP	Reier et al. , 1989	26920
@NP	Reier	26920
@NP	et al. , 1989	26926
@NP	et al.	26926
@NP	1989	26934
@NP	Zhang et al. , 2005	26940
@NP	Zhang	26940
@NP	et al. , 2005	26946
@NP	et al.	26946
@NP	2005	26954
@NP	Zhang et al. , 2007	26960
@NP	Zhang	26960
@NP	et al. , 2007	26966
@NP	et al.	26966
@NP	2007	26974
@NP	levels of CSPGs	26999
@NP	levels	26999
@NP	CSPGs	27009
@NP	time	27035
@NP	the physical structure	27041
@NP	glial scar tissue	27067
@NP	GFAP immunoreactivity	27103
@NP	much difference -LRB- Camand et al. , 2004 -RRB-	27139
@NP	much difference	27139
@NP	Camand	27156
@NP	et al. , 2004	27163
@NP	et al.	27163
@NP	2004	27171
@NP	Our observations	27178
@NP	22 weeks	27209
@NP	SCI	27224
@NP	the glial scar and lesion cavity	27228
@NP	the injury site	27282
@NP	prominent modification	27306
@NP	that seen 6 weeks after injury	27348
@NP	that	27348
@NP	6 weeks	27358
@NP	injury	27372
@NP	LP and/or OEC transplantation after scar ablation	27394
@NP	LP	27394
@NP	OEC transplantation after scar ablation	27404
@NP	OEC transplantation	27404
@NP	scar ablation	27430
@NP	numerous cells including Schwann cells	27445
@NP	numerous cells	27445
@NP	Schwann cells	27470
@NP	the repaired tissue toward and fill the lesion cavity	27497
@NP	the repaired tissue	27497
@NP	the lesion cavity	27533
@NP	the integration of repaired tissue with the spared tissue	27565
@NP	the integration	27565
@NP	repaired tissue with the spared tissue	27584
@NP	repaired tissue	27584
@NP	the spared tissue	27605
@NP	almost no space	27636
@NP	the reformation of ablated glial scar -LRB- Fig. 4D and E -RRB-	27656
@NP	the reformation	27656
@NP	ablated glial scar -LRB- Fig. 4D and E -RRB-	27675
@NP	ablated glial scar	27675
@NP	Fig. 4D and E	27695
@NP	Fig. 4D	27695
@NP	E	27707
@NP	there	27723
@NP	no integration of repaired tissue	27732
@NP	no integration	27732
@NP	repaired tissue	27750
@NP	tissue	27777
@NP	the scar reformation	27785
@NP	Fig. 4C	27823
@NP	The number of P0-positive myelin sheaths in the rats with combination treatments	27833
@NP	The number	27833
@NP	P0-positive myelin sheaths in the rats with combination treatments	27847
@NP	P0-positive myelin sheaths	27847
@NP	the rats with combination treatments	27877
@NP	the rats	27877
@NP	combination treatments	27891
@NP	that in the injury	27943
@NP	that	27943
@NP	the injury	27951
@NP	rats	27975
@NP	the combination treatments	27997
@NP	the P0-positive myelination	28036
@NP	many studies	28075
@NP	evidence	28099
@NP	Schwann cells but not OECs	28113
@NP	Schwann cells	28113
@NP	Schwann	28113
@NP	cells	28121
@NP	OECs	28135
@NP	the regenerating axons	28150
@NP	OECs	28174
@NP	the axons -- unmyelinated fibers	28193
@NP	the axons	28193
@NP	unmyelinated fibers	28203
@NP	Boyd	28224
@NP	et al. , 2004 ; Boyd et al. , 2005 ; Ramer et al. , 2004 ; Takami et al. , 2002	28229
@NP	et al. , 2004	28229
@NP	et al.	28229
@NP	2004	28237
@NP	Boyd et al. , 2005	28243
@NP	Boyd	28243
@NP	et al. , 2005	28248
@NP	et al.	28248
@NP	2005	28256
@NP	Ramer et al. , 2004	28262
@NP	Ramer	28262
@NP	et al. , 2004	28268
@NP	et al.	28268
@NP	2004	28276
@NP	Takami et al. , 2002	28282
@NP	Takami	28282
@NP	et al. , 2002	28289
@NP	et al.	28289
@NP	2002	28297
@NP	they	28313
@NP	the same origin	28328
@NP	the neural crest -LRB- Barraud et al. , 2010 -RRB-	28349
@NP	the neural crest	28349
@NP	Barraud	28367
@NP	et al. , 2010	28375
@NP	et al.	28375
@NP	2010	28383
@NP	Our previous study	28390
@NP	the regenerating axons	28422
@NP	Schwann cells	28464
@NP	almost 9 times more unmyelinated axons	28483
@NP	the electron microscope in a hemisection model of rat	28538
@NP	the electron microscope	28538
@NP	a hemisection model of rat	28565
@NP	a hemisection model	28565
@NP	rat	28588
@NP	the number of myelinated axons	28593
@NP	the number	28593
@NP	myelinated axons	28607
@NP	the axonal regeneration -LRB- Xu et al. , 1999 -RRB-	28649
@NP	the axonal regeneration	28649
@NP	Xu	28674
@NP	et al. , 1999	28677
@NP	et al.	28677
@NP	1999	28685
@NP	The myelin sheaths formed by Schwann cells at the injury site	28692
@NP	The myelin sheaths	28692
@NP	Schwann cells	28721
@NP	the injury site	28738
@NP	monoclonal antibody P0 -LRB- Allen et al. , 2005 ; Yoshimura et al. , 1996 -RRB-	28778
@NP	monoclonal antibody P0	28778
@NP	Allen	28802
@NP	et al. , 2005 ; Yoshimura et al. , 1996	28808
@NP	et al.	28808
@NP	2005 ; Yoshimura et al.	28816
@NP	2005	28816
@NP	Yoshimura et al.	28822
@NP	Yoshimura	28822
@NP	et al.	28832
@NP	1996	28840
@NP	it	28860
@NP	all the axons	28880
@NP	the regenerating -LRB- myelinated and unmyelinated -RRB- ones	28904
@NP	myelinated and unmyelinated	28922
@NP	the injury site	28959
@NP	light or electron microscopy	28985
@NP	it	29026
@NP	the number	29050
@NP	P0-positive myelin sheaths	29064
@NP	the epicenter as an indicator	29105
@NP	the epicenter	29105
@NP	an indicator	29122
@NP	the trend of axonal regeneration	29147
@NP	the trend	29147
@NP	axonal regeneration	29160
@NP	The increase in number of P0 - positive myelin sheaths	29181
@NP	The increase	29181
@NP	number of P0 - positive myelin sheaths	29197
@NP	number of P0	29197
@NP	number	29197
@NP	P0	29207
@NP	myelin sheaths	29220
@NP	the effect	29251
@NP	endogenous Schwann cells	29265
@NP	transplanted OECs -LRB- Eftekharpour et al. , 2008 ; Pearse et al. , 2007 -RRB-	29304
@NP	transplanted OECs	29304
@NP	Eftekharpour	29323
@NP	et al. , 2008 ; Pearse et al. , 2007	29336
@NP	et al.	29336
@NP	2008 ; Pearse et al.	29344
@NP	2008	29344
@NP	Pearse et al.	29350
@NP	Pearse	29350
@NP	et al.	29357
@NP	2007	29365
@NP	these observations	29381
@NP	we	29401
@NP	the combination treatments including scar ablation and transplantation of LP/OEC	29417
@NP	the combination treatments	29417
@NP	scar ablation and transplantation of LP/OEC	29454
@NP	scar ablation and transplantation	29454
@NP	LP/OEC	29491
@NP	the tissue repair	29515
@NP	the P0-positive myelination , which may imply the axonal regeneration	29543
@NP	the P0-positive myelination	29543
@NP	the axonal regeneration	29588
@NP	this study , remarkable tissue repair and increase of P0	29616
@NP	this study	29616
@NP	remarkable tissue repair	29628
@NP	increase of P0	29657
@NP	increase	29657
@NP	P0	29669
@NP	positive myelination	29673
@NP	significant locomotor recovery	29712
@NP	The reasons	29744
@NP	poor neural plasticity	29799
@NP	the injury	29828
@NP	One possibility	29840
@NP	those regenerating axons	29864
@NP	the target location	29906
@NP	effective synaptic connection	29939
@NP	Another possibility	29970
@NP	most of these regenerating axons	29998
@NP	most	29998
@NP	these regenerating axons	30006
@NP	abnormal or non-existent impulse conduction	30036
@NP	SCI locomotor	30087
@NP	recovery	30101
@NP	an effective number of regenerating axons	30126
@NP	an effective number	30126
@NP	regenerating axons	30149
@NP	reestablishment of synaptic connections	30169
@NP	reestablishment	30169
@NP	synaptic connections	30188
@NP	restoration of nerve conduction	30210
@NP	restoration	30210
@NP	nerve conduction	30225
@NP	the remaining ability	30246
@NP	muscle movement	30271
@NP	Carlson	30288
@NP	1989	30297
@NP	Collazos-Castro	30303
@NP	et al. , 2006 ; Fawcett , 2002 ; Fry , 2001 ; Schwab , 2002 ; Young , 1989	30319
@NP	et al. , 2006	30319
@NP	et al.	30319
@NP	2006	30327
@NP	Fawcett , 2002	30333
@NP	Fawcett	30333
@NP	2002	30342
@NP	Fry , 2001	30348
@NP	Fry	30348
@NP	2001	30353
@NP	Schwab , 2002	30359
@NP	Schwab	30359
@NP	2002	30367
@NP	Young , 1989	30373
@NP	Young	30373
@NP	1989	30380
@NP	the present study	30390
@NP	we	30408
@NP	a number of P0-positive myelination	30420
@NP	a number	30420
@NP	P0-positive myelination	30432
@NP	the injury epicenter	30459
@NP	we	30485
@NP	these axons	30503
@NP	functional locations	30528
@NP	new synaptic connections	30567
@NP	All this	30593
@NP	additional therapies , such as the administration of physical therapy	30616
@NP	additional therapies	30616
@NP	the administration of physical therapy	30646
@NP	the administration	30646
@NP	physical therapy	30668
@NP	the elongation of regenerating axons	30715
@NP	the elongation	30715
@NP	regenerating axons	30733
@NP	effective synaptic connections	30798
@NP	the formation of activitydependent plasticity	30848
@NP	the formation	30848
@NP	activitydependent plasticity	30865
@NP	both sensory	30905
@NP	motor function -LRB- Barnett and Chang , 2004 ; Barnett and Riddell , 2007 -RRB-	30922
@NP	motor function	30922
@NP	Barnett and Chang , 2004 ; Barnett and Riddell , 2007	30938
@NP	Barnett and Chang	30938
@NP	2004 ; Barnett and Riddell	30957
@NP	2004	30957
@NP	Barnett and Riddell	30963
@NP	2007	30984
@NP	conclusion	30994
@NP	the data from this study	31006
@NP	the data	31006
@NP	this study	31020
@NP	chronically contused rat spinal cord	31047
@NP	spontaneous repair processes	31085
@NP	tissue	31147
@NP	combination treatments	31187
@NP	scar ablation and LP/OEC transplantation	31215
@NP	scar ablation	31215
@NP	LP/OEC transplantation	31233
@NP	Tissue repair	31257
@NP	profound expansion	31288
@NP	endogenous	31310
@NP	tissue	31330
@NP	remarkable reduction or disappearance of the lesion cavity	31338
@NP	remarkable reduction or disappearance	31338
@NP	the lesion cavity	31379
@NP	integration of repaired tissue with spared tissue	31402
@NP	integration	31402
@NP	repaired tissue with spared tissue	31417
@NP	repaired tissue	31417
@NP	spared tissue	31438
@NP	a beneficial environment	31464
@NP	axonal regeneration and prevention	31493
@NP	scar reformation	31531
@NP	The findings in this study	31549
@NP	The findings	31549
@NP	this study	31565
@NP	removal of an existing glial scar	31598
@NP	removal	31598
@NP	an existing glial scar	31609
@NP	the tissue repair	31649
@NP	the combination treatments	31677
@NP	significant locomotion improvement	31722
@NP	these findings	31758
@NP	further study	31811
@NP	the functional recovery	31836
@NP	the functional electrical stimulation-based physical therapy	31872
@NP	Experimental procedures 4.1 .	31938
@NP	Experimental procedures	31938
@NP	4.1	31962
@NP	Animal Adult female Long -- Evans rats weighing 200 -- 220 g	31967
@NP	Animal Adult female Long	31967
@NP	Animal Adult	31967
@NP	Evans rats	31992
@NP	200	32012
@NP	220 g	32016
@NP	the present study	32036
@NP	They	32055
@NP	plastic cages on 12 h light/dark cycles	32082
@NP	plastic cages	32082
@NP	12 h light/dark cycles	32099
@NP	free moving space and free access to drinking water and standard food	32127
@NP	free moving space	32127
@NP	free access to drinking water and standard food	32149
@NP	free access	32149
@NP	drinking water and standard food	32164
@NP	drinking water	32164
@NP	standard food	32183
@NP	All rats	32198
@NP	contusion injury	32216
@NP	several groups -LRB- Table 1 -RRB-	32264
@NP	several groups	32264
@NP	Table 1	32280
@NP	The control animals	32290
@NP	contusion injury only -LRB- SCI Control , i.e. , SCI 22w , n = 10 -RRB-	32319
@NP	contusion injury only	32319
@NP	contusion injury	32319
@NP	SCI Control , i.e.	32342
@NP	SCI Control	32342
@NP	i.e.	32355
@NP	SCI 22w , n = 10	32361
@NP	SCI 22w	32361
@NP	n = 10	32370
@NP	n	32370
@NP	10	32372
@NP	the rest	32380
@NP	scar ablation/transplantation	32398
@NP	6 weeks	32428
@NP	SCI	32442
@NP	Animals in two groups	32447
@NP	Animals	32447
@NP	two groups	32458
@NP	LP -LRB- SCI+LP , n = 11 -RRB- or LP	32478
@NP	LP -LRB- SCI+LP , n = 11 -RRB-	32478
@NP	LP	32478
@NP	SCI+LP , n = 11	32482
@NP	SCI+LP	32482
@NP	n = 11	32490
@NP	n	32490
@NP	11	32492
@NP	LP	32499
@NP	OEC -LRB- SCI+LP+OEC , n = 10 -RRB- transplantation	32507
@NP	OEC	32507
@NP	SCI+LP+OEC , n = 10	32512
@NP	SCI+LP+OEC	32512
@NP	n = 10	32524
@NP	n	32524
@NP	10	32526
@NP	transplantation	32530
@NP	scar ablation	32554
@NP	Animals in the other three groups	32569
@NP	Animals	32569
@NP	the other three groups	32580
@NP	scar ablation -LRB- SCI+SA , n = 12 -RRB-	32612
@NP	scar ablation	32612
@NP	SCI+SA , n = 12	32627
@NP	SCI+SA	32627
@NP	n = 12	32635
@NP	n	32635
@NP	12	32637
@NP	scar ablation	32644
@NP	LP -LRB- SCI+SA+LP , n = 8 -RRB-	32670
@NP	LP	32670
@NP	SCI+SA+LP , n = 8	32674
@NP	SCI+SA+LP	32674
@NP	n = 8	32685
@NP	n	32685
@NP	8	32687
@NP	LP plus OEC -LRB- SCI+SA+LP+OEC , n = 11 -RRB- transplantation	32693
@NP	LP	32693
@NP	OEC -LRB- SCI+SA+LP+OEC , n = 11 -RRB- transplantation	32701
@NP	OEC	32701
@NP	SCI+SA+LP+OEC , n = 11	32706
@NP	SCI+SA+LP+OEC	32706
@NP	n = 11	32721
@NP	n	32721
@NP	11	32723
@NP	transplantation	32727
@NP	deep anesthesia with sodium pentobarbital -LRB- 60 mg/kg , ip -RRB-	32750
@NP	deep anesthesia	32750
@NP	sodium pentobarbital -LRB- 60 mg/kg , ip -RRB-	32771
@NP	sodium pentobarbital	32771
@NP	60 mg/kg , ip	32793
@NP	60 mg/kg	32793
@NP	ip	32803
@NP	all animals	32808
@NP	phosphatebuffered 4 % paraformaldehyde 22 weeks	32854
@NP	phosphatebuffered 4 % paraformaldehyde	32854
@NP	22 weeks	32892
@NP	contusion injury or 16 weeks	32907
@NP	contusion injury	32907
@NP	16 weeks	32927
@NP	transplantation	32942
@NP	addition	32962
@NP	5 additional control rats -LRB- SCI 6w -RRB-	32972
@NP	5 additional control rats	32972
@NP	SCI 6w	32999
@NP	6 weeks	33021
@NP	contusion injury	33035
@NP	the study of glial scar formation	33056
@NP	the study	33056
@NP	glial scar formation	33069
@NP	P0	33094
@NP	positive myelin sheath evaluation	33098
@NP	3 rats	33137
@NP	8 weeks	33158
@NP	scar ablation	33172
@NP	transplantation for the study of glial scar reformation	33194
@NP	transplantation	33194
@NP	the study of glial scar reformation	33214
@NP	the study	33214
@NP	glial scar reformation	33227
@NP	All spinal cords	33251
@NP	histological evaluation	33287
@NP	All surgical procedures , including interventions and preand post-surgery care ,	33312
@NP	All surgical procedures	33312
@NP	interventions and preand post-surgery care	33347
@NP	interventions	33347
@NP	preand post-surgery care	33365
@NP	the Institutional Animal Use and Care Committee of Colorado	33408
@NP	the Institutional Animal Use and Care Committee	33408
@NP	Colorado	33459
@NP	the Guide for the Care and Use of Laboratory Animals -LRB- 1996 -RRB-	33492
@NP	the Guide for the Care and Use of Laboratory Animals	33492
@NP	the Care	33506
@NP	Laboratory	33526
@NP	1996	33546
@NP	4.2	33553
@NP	Characterization of primary antibodies	33558
@NP	Characterization	33558
@NP	primary antibodies	33578
@NP	Table 2 for a list of all primary antibodies used in this study	33613
@NP	Table 2	33613
@NP	a list of all primary antibodies used in this study	33625
@NP	a list	33625
@NP	all primary antibodies used in this study	33635
@NP	all primary antibodies	33635
@NP	this study	33666
@NP	The GFAP antibodies	33678
@NP	cells	33711
@NP	the classic morphology and distribution of glial fibrillary acidic protein	33722
@NP	the classic morphology and distribution	33722
@NP	glial fibrillary acidic protein	33765
@NP	a pattern that is identical to that previously reported	33808
@NP	a pattern	33808
@NP	that previously reported	33839
@NP	that	33839
@NP	Moon and Fawcett	33865
@NP	2001	33883
@NP	The anti-P0 antibody	33890
@NP	the IgG or IgM class	33923
@NP	the expected myelin sheaths of peripheral nerve in paraffin-embedded sections	33965
@NP	the expected myelin sheaths	33965
@NP	peripheral nerve	33996
@NP	paraffin-embedded sections	34016
@NP	the myelin sheathes	34052
@NP	the normal spinal cord -LRB- Buss et al. , 2007 ; Lee et al. , 1997 -RRB-	34075
@NP	the normal spinal cord	34075
@NP	Buss	34099
@NP	et al. , 2007 ; Lee et al. , 1997	34104
@NP	et al.	34104
@NP	2007 ; Lee et al.	34112
@NP	2007	34112
@NP	Lee et al.	34118
@NP	Lee	34118
@NP	et al.	34122
@NP	1997	34130
@NP	P0-positive myelin sheaths in the repaired tissue	34137
@NP	P0-positive myelin sheaths	34137
@NP	the repaired tissue	34167
@NP	newly formed myelin sheaths which contain an axon	34206
@NP	an axon	34248
@NP	The α-p75NTR antibody	34257
@NP	larger	34290
@NP	olfactory ensheathing cells and small spindle-shaped Schwann cells	34305
@NP	the culture	34375
@NP	previous description	34411
@NP	Mackay-Sim , 2005 ; Plant et al. , 2002 ; Shyu et al. , 2008	34433
@NP	Mackay-Sim	34433
@NP	2005 ; Plant et al. , 2002 ; Shyu et al.	34445
@NP	2005	34445
@NP	Plant et al. , 2002 ; Shyu et al.	34451
@NP	Plant	34451
@NP	et al. , 2002 ; Shyu et al.	34457
@NP	et al. , 2002	34457
@NP	et al.	34457
@NP	2002	34465
@NP	Shyu et al.	34471
@NP	Shyu	34471
@NP	et al.	34476
@NP	2008	34484
@NP	Mouse monoclonal antibody against neurofilament , a widely used antibody ,	34491
@NP	Mouse monoclonal antibody against neurofilament	34491
@NP	Mouse monoclonal antibody	34491
@NP	neurofilament	34525
@NP	a widely used antibody	34540
@NP	all axons	34575
@NP	the spinal cord	34588
@NP	The basic morphology of stained axons	34605
@NP	The basic morphology	34605
@NP	axons	34637
@NP	previous description -LRB- Schmidt et al. , 1987 ; Trojanowski , 1987 -RRB-	34662
@NP	previous description	34662
@NP	Schmidt	34684
@NP	et al. , 1987 ; Trojanowski , 1987	34692
@NP	et al.	34692
@NP	1987 ; Trojanowski	34700
@NP	1987	34700
@NP	Trojanowski	34706
@NP	1987	34719
@NP	4.3	34726
@NP	Preparation of LP and OECs for transplantation 4.3.1 .	34731
@NP	Preparation	34731
@NP	LP and OECs	34746
@NP	transplantation 4.3.1	34762
@NP	Preparation	34785
@NP	LP	34800
@NP	The olfactory mucosa , devoid of the respiratory mucosa ,	34803
@NP	The olfactory mucosa	34803
@NP	the respiratory mucosa	34835
@NP	the nasal septum of a donor animal	34877
@NP	the nasal septum	34877
@NP	a donor animal	34897
@NP	Dispase II -LRB- Roche -RRB- for 35	34930
@NP	Dispase II -LRB- Roche -RRB-	34930
@NP	Dispase II	34930
@NP	Roche	34942
@NP	35	34953
@NP	40 min at 37 °C	34956
@NP	40 min	34956
@NP	37 °C	34966
@NP	The olfactory epithelium	34973
@NP	forceps thereby exposing the LP -LRB- Fig. 1A and B -RRB-	35028
@NP	forceps	35028
@NP	the LP -LRB- Fig. 1A and B -RRB-	35053
@NP	the LP	35053
@NP	Fig. 1A and B	35061
@NP	Fig. 1A	35061
@NP	B	35073
@NP	transplant	35081
@NP	the LP	35093
@NP	2.0 × 2.0 mm -LRB- LP-Only -RRB- or 1.5 × 1.5 mm -LRB- LP+OEC s -RRB- squares	35113
@NP	2.0 × 2.0 mm -LRB- LP-Only -RRB-	35113
@NP	2.0 × 2.0 mm	35113
@NP	2.0 ×	35113
@NP	2.0 mm	35117
@NP	LP-Only	35124
@NP	1.5 × 1.5 mm -LRB- LP+OEC s -RRB- squares	35136
@NP	1.5	35136
@NP	× 1.5 mm -LRB- LP+OEC s -RRB- squares	35139
@NP	LP+OEC s	35147
@NP	ice in L-15	35176
@NP	ice	35176
@NP	L-15	35183
@NP	transplant	35194
@NP	One piece of LP	35206
@NP	One piece	35206
@NP	LP	35219
@NP	one rat	35235
@NP	4.3.2	35244
@NP	Preparation of OECs OECs	35251
@NP	Preparation	35251
@NP	OECs OECs	35266
@NP	adult Long	35295
@NP	Evans LP following basic protocols	35306
@NP	Evans LP	35306
@NP	basic protocols	35325
@NP	elsewhere -LRB- Au and Roskams , 2002 -RRB-	35350
@NP	elsewhere	35350
@NP	Au and Roskams	35361
@NP	2002	35377
@NP	OEC culture	35400
@NP	LP isolated as described above	35413
@NP	LP	35413
@NP	37 °C in collagenase	35460
@NP	37 °C	35460
@NP	collagenase	35469
@NP	30 min	35485
@NP	incubation	35504
@NP	SD -LRB- Soybean Trypsin inhibitor/DNase -RRB- solution for 15 min	35518
@NP	SD -LRB- Soybean Trypsin inhibitor/DNase -RRB- solution	35518
@NP	SD -LRB- Soybean Trypsin inhibitor/DNase -RRB-	35518
@NP	SD	35518
@NP	Soybean Trypsin inhibitor/DNase	35522
@NP	15 min	35568
@NP	The tissue	35576
@NP	3 times	35616
@NP	22	35632
@NP	25 gauge	35639
@NP	growth medium	35661
@NP	400 × g	35684
@NP	growth	35705
@NP	medium on a matrigel-coated T25 flask	35712
@NP	medium	35712
@NP	a matrigel-coated T25 flask	35722
@NP	Twenty-four hours	35751
@NP	non-adherent cells	35784
@NP	fresh media	35820
@NP	the culture	35848
@NP	Cultures	35861
@NP	an additional 4	35885
@NP	7 days until nearly confluent	35901
@NP	7 days	35901
@NP	contaminating fibroblasts	35947
@NP	the OEC cultures -LRB- Noble and Murray , 1984 -RRB-	35978
@NP	the OEC cultures	35978
@NP	Noble and Murray	35996
@NP	1984	36014
@NP	cells	36021
@NP	some Schwann cells -LRB- Rizek and Kawaja , 2006 -RRB-	36057
@NP	some Schwann cells	36057
@NP	Rizek and Kawaja	36077
@NP	2006	36095
@NP	liquid nitrogen in working aliquots	36130
@NP	liquid nitrogen	36130
@NP	working aliquots	36149
@NP	4.3.3	36167
@NP	Immunostaining of cell cultures	36174
@NP	Immunostaining	36174
@NP	cell cultures	36192
@NP	transplantation , cultures of CD90-negative OECs	36215
@NP	transplantation	36215
@NP	cultures of CD90-negative OECs	36232
@NP	cultures	36232
@NP	CD90-negative OECs	36244
@NP	matrigel-coated 8-well chamber slides	36278
@NP	a density of ~ 3000 cells/cm2	36319
@NP	a density	36319
@NP	~ 3000 cells/cm2	36332
@NP	the following day	36352
@NP	cells	36371
@NP	1	36389
@NP	PBS	36397
@NP	4 % paraformaldehyde	36411
@NP	4 % goat serum in 0.1 % Triton X-100 / PBS	36479
@NP	4 % goat serum	36479
@NP	0.1 % Triton X-100 / PBS	36496
@NP	0.1 % Triton X-100	36496
@NP	PBS	36514
@NP	Cellswere	36519
@NP	1:100 mouse α-p75NTR -LRB- Abcam , Cambridge , MA #MC -192 -RRB-	36557
@NP	1:100 mouse α-p75NTR	36557
@NP	Abcam , Cambridge , MA #MC -192	36578
@NP	1:500 rabbit	36612
@NP	α-glial fibrillary acidic protein -LRB- GFAP -RRB-	36625
@NP	α-glial fibrillary acidic protein	36625
@NP	GFAP	36660
@NP	Dako , Glostrup Denmark #Z0334	36667
@NP	Dako	36667
@NP	Glostrup Denmark #Z0334	36673
@NP	1 h	36702
@NP	room temperature	36709
@NP	Primary antibodies	36727
@NP	a 1:1000 dilution goat anti-mouse IgG Alexa-568	36765
@NP	a 1:1000 dilution goat	36765
@NP	anti-mouse IgG Alexa-568	36788
@NP	goat anti-rabbit Alexa-488	36817
@NP	secondary antibodies -LRB- Molecular Probes , Eugene , OR -RRB-	36844
@NP	secondary antibodies	36844
@NP	Molecular Probes	36866
@NP	Eugene	36884
@NP	OR	36892
@NP	aqua polymount -LRB- Polyscience , Niles , IL -RRB-	36918
@NP	aqua polymount	36918
@NP	Polyscience	36934
@NP	Niles	36947
@NP	IL	36954
@NP	cellswere stainedwith 2 μg/ml Hoeschst -LRB- Sigma , St.	36959
@NP	cellswere stainedwith	36959
@NP	2 μg/ml Hoeschst -LRB- Sigma , St.	36981
@NP	2 μg/ml Hoeschst	36981
@NP	Sigma	36999
@NP	St.	37006
@NP	Louis , MO -RRB- for 5 min .	37010
@NP	Louis , MO -RRB- for 5 min	37010
@NP	Louis , MO -RRB-	37010
@NP	Louis	37010
@NP	5 min	37025
@NP	Images	37031
@NP	an Olympus IX70 inverted microscope	37057
@NP	a FVII camera -LRB- Olympus -RRB-	37107
@NP	a FVII camera	37107
@NP	Olympus	37122
@NP	Microsuite imaging software -LRB- Olympus -RRB- -LRB- Fig. 1C -RRB-	37135
@NP	Microsuite imaging software -LRB- Olympus -RRB-	37135
@NP	Microsuite imaging software	37135
@NP	Olympus	37164
@NP	Fig. 1C	37174
@NP	4.4	37184
@NP	Spinal cord injury	37189
@NP	postoperative animal care The contusion injury to the rat spinal cord	37212
@NP	postoperative animal care	37212
@NP	The contusion injury to the rat spinal cord	37238
@NP	The contusion injury	37238
@NP	the rat spinal cord	37262
@NP	the NYU -LRB- New York University -RRB- impactor device as described before	37303
@NP	the NYU -LRB- New York University -RRB- impactor device	37303
@NP	New York University	37312
@NP	Zhang	37370
@NP	et al. , 2000	37376
@NP	et al.	37376
@NP	2000	37384
@NP	deep anesthesia with sodium pentobarbital -LRB- 50 mg/kg , ip -RRB-	37406
@NP	deep anesthesia	37406
@NP	sodium pentobarbital -LRB- 50 mg/kg , ip -RRB-	37427
@NP	sodium pentobarbital	37427
@NP	50 mg/kg , ip	37449
@NP	50 mg/kg	37449
@NP	ip	37459
@NP	the vertebral column	37464
@NP	the spinous process	37517
@NP	vertebra	37540
@NP	thoracic -LRB- T -RRB- level T7 and T10	37549
@NP	thoracic -LRB- T -RRB-	37549
@NP	level T7 and T10	37562
@NP	a dorsal laminectomy	37580
@NP	the spinal cord	37619
@NP	the dura intact	37652
@NP	the dura	37652
@NP	the 10 g impact rod	37674
@NP	spinal cord segment T10	37709
@NP	a height of 25 mm	37738
@NP	a height	37738
@NP	25 mm	37750
@NP	it	37761
@NP	hind limb	37776
@NP	locomotor deficits as described previously	37786
@NP	locomotor deficits	37786
@NP	Constantini and Young	37830
@NP	1994	37853
@NP	pain	37871
@NP	analgesia buprenorphine -LRB- 0.02 mg/kg , sc -RRB-	37877
@NP	analgesia buprenorphine	37877
@NP	0.02 mg/kg , sc	37902
@NP	0.02 mg/kg	37902
@NP	sc	37914
@NP	the first 2 days	37947
@NP	injury/surgery	37970
@NP	The antibiotic cephazolin -LRB- 20 mg/kg , sc -RRB-	37986
@NP	The antibiotic cephazolin	37986
@NP	20 mg/kg , sc	38013
@NP	20 mg/kg	38013
@NP	sc	38023
@NP	twice a day	38040
@NP	one week	38056
@NP	Urinary bladders	38066
@NP	hand	38109
@NP	twice a day	38114
@NP	adequate spontaneous voiding returned	38132
@NP	adequate spontaneous voiding	38132
@NP	attention	38174
@NP	the body	38201
@NP	addition	38218
@NP	saline solution -LRB- 0.9 % , 10 ml , sc -RRB-	38228
@NP	saline solution	38228
@NP	0.9 %	38245
@NP	10 ml	38251
@NP	sc	38258
@NP	one	38289
@NP	week	38293
@NP	dehydration	38309
@NP	The animals	38322
@NP	the first two weeks	38360
@NP	surgery and once a week	38386
@NP	surgery	38386
@NP	once a week	38398
@NP	Animals	38421
@NP	5 -- 10 % of their body weight	38442
@NP	5	38442
@NP	10 % of their body weight	38444
@NP	10 %	38444
@NP	their body weight	38451
@NP	the first week	38476
@NP	injury	38497
@NP	the loss of body weight	38508
@NP	the loss	38508
@NP	body weight	38520
@NP	more than 15 %	38536
@NP	more saline solution	38551
@NP	more saline	38551
@NP	solution	38563
@NP	4.5	38583
@NP	Photochemical scar ablation	38588
@NP	Six weeks	38616
@NP	contusion injury photochemical scar ablation	38632
@NP	contusion injury	38632
@NP	the injury epicenter	38694
@NP	the spinal cord as previously described -LRB- Zhang et al. , 2007 -RRB-	38718
@NP	the spinal cord	38718
@NP	Zhang	38759
@NP	et al. , 2007	38765
@NP	et al.	38765
@NP	2007	38773
@NP	deep anesthesia with sodium pentobarbital	38795
@NP	deep anesthesia	38795
@NP	sodium pentobarbital	38816
@NP	the wound	38838
@NP	the injury site of the spinal cord	38865
@NP	the injury site	38865
@NP	the spinal cord	38884
@NP	dura intact	38917
@NP	dura	38917
@NP	One -LRB- 1.0 -RRB- microliter of 2 %	38930
@NP	One -LRB- 1.0 -RRB- microliter	38930
@NP	One -LRB- 1.0 -RRB-	38930
@NP	One	38930
@NP	1.0	38935
@NP	2 %	38954
@NP	Bengal in saline	38962
@NP	Bengal	38962
@NP	saline	38972
@NP	the course of 1 min	39013
@NP	the course	39013
@NP	1 min	39027
@NP	the lesion cavity	39038
@NP	a narrow bore -LRB- ~ 100 μm -RRB-	39064
@NP	a narrow bore	39064
@NP	a narrow	39064
@NP	~ 100 μm	39079
@NP	glass pipette connected to a Digital Microdispenser	39089
@NP	glass pipette	39089
@NP	a Digital Microdispenser	39116
@NP	Drummond Scientific Co. , Broomall , PA , USA	39142
@NP	Drummond Scientific Co.	39142
@NP	Broomall	39167
@NP	PA	39177
@NP	USA	39181
@NP	The	39187
@NP	Bengal within the cavity	39196
@NP	Bengal	39196
@NP	the cavity	39210
@NP	8 min	39248
@NP	injection	39260
@NP	the cytoplasm of the superficial astrocytes of the glial scar tissue	39299
@NP	the cytoplasm	39299
@NP	the superficial astrocytes of the glial scar tissue	39316
@NP	the superficial astrocytes	39316
@NP	the glial scar tissue	39346
@NP	the injury site	39369
@NP	5 min	39405
@NP	the full spectrum light of a halogen bulb -LRB- 150 W , 7 cm distance -RRB-	39415
@NP	the full spectrum light	39415
@NP	a halogen bulb -LRB- 150 W , 7 cm distance -RRB-	39442
@NP	a halogen bulb	39442
@NP	150 W	39458
@NP	7 cm distance	39465
@NP	damage	39492
@NP	the cord tissue	39502
@NP	the heating source from the halogen light	39521
@NP	the heating source	39521
@NP	the halogen light	39545
@NP	the exposed part of spinal cord	39564
@NP	the exposed part	39564
@NP	spinal cord	39584
@NP	room temperature saline solution	39612
@NP	fresh change each 30 -- 40 s during the illuminating time	39650
@NP	fresh change each 30	39650
@NP	fresh change each	39650
@NP	fresh change	39650
@NP	each	39663
@NP	30	39668
@NP	40 s during the illuminating time	39671
@NP	40 s	39671
@NP	the illuminating time	39683
@NP	the absorption of rose Bengal by glial scar cells	39717
@NP	the absorption	39717
@NP	Bengal	39740
@NP	glial scar cells	39750
@NP	two rats	39768
@NP	phosphatebuffered 4 % paraformaldehyde 8 min	39811
@NP	Bengal injection	39866
@NP	the lesion cavity	39888
@NP	light illumination	39914
@NP	the spinal cords	39934
@NP	cryosection	39970
@NP	Sections without any staining	39983
@NP	Sections	39983
@NP	any staining	40000
@NP	the light microscope	40033
@NP	the location of rose Bengal within the lesion cavity -LRB- Fig. 2C -RRB-	40066
@NP	the location	40066
@NP	Bengal	40087
@NP	the lesion cavity -LRB- Fig. 2C -RRB-	40101
@NP	the lesion cavity	40101
@NP	Fig. 2C	40120
@NP	4.6	40130
@NP	Implantation of LP or OECs Implantation	40135
@NP	Implantation	40135
@NP	LP or OECs Implantation	40151
@NP	LP	40151
@NP	OECs Implantation	40157
@NP	the injury site	40206
@NP	photochemical scar ablation	40243
@NP	the surgical microscope	40278
@NP	the dura	40302
@NP	a 1 mm long opening of the lesion cavity	40342
@NP	a 1 mm long opening	40342
@NP	1 mm	40344
@NP	the lesion cavity	40365
@NP	a sharp blade on the median line of spinal cord	40397
@NP	a sharp blade	40397
@NP	the median line of spinal cord	40414
@NP	the median line	40414
@NP	spinal cord	40433
@NP	the injury epicenter	40448
@NP	One piece of the soft LP	40470
@NP	One piece	40470
@NP	the soft LP	40483
@NP	the cavity with the help of forceps	40524
@NP	the cavity	40524
@NP	the help of forceps	40540
@NP	the help	40540
@NP	forceps	40552
@NP	two groups	40564
@NP	1 or 2 μl of OECs	40576
@NP	1 or 2 μl	40576
@NP	OECs	40589
@NP	6 × 106	40595
@NP	6 ×	40595
@NP	106	40597
@NP	suspension	40602
@NP	the opening cavity	40631
@NP	a 31 gauge metal needle connected to a Hamilton syringe prior LP delivery	40658
@NP	a 31 gauge metal needle	40658
@NP	a Hamilton syringe	40695
@NP	LP delivery	40720
@NP	the dura	40744
@NP	a 10	40781
@NP	0 Novafil nylon suture -LRB- Ethicon , Somerville , NJ , USA -RRB-	40786
@NP	0 Novafil nylon suture	40786
@NP	Ethicon	40810
@NP	Somerville	40819
@NP	NJ , USA	40831
@NP	the invasion of connective tissue scar	40850
@NP	the invasion	40850
@NP	connective tissue scar	40866
@NP	The muscle and skin	40890
@NP	proper sutures	40927
@NP	glial scar	40959
@NP	the transplanted LP	40985
@NP	the lesion cavity	41023
@NP	two rats	41042
@NP	2 h	41065
@NP	scar ablation and LP transplantation	41075
@NP	scar ablation	41075
@NP	LP transplantation	41093
@NP	the spinal cords	41117
@NP	histological observation	41153
@NP	others -LRB- Fig. 2D -RRB-	41181
@NP	others	41181
@NP	Fig. 2D	41189
@NP	the survival of transplanted LP	41233
@NP	the survival	41233
@NP	transplanted LP	41249
@NP	we	41265
@NP	GFP-positive LP	41281
@NP	the lesion cavity	41302
@NP	the same procedures asmentioned above	41325
@NP	the same procedures	41325
@NP	the tissues	41372
@NP	a GFP-positive strain of Sprague -- Dawley rats	41402
@NP	a GFP-positive strain of Sprague	41402
@NP	a GFP-positive strain	41402
@NP	Sprague	41427
@NP	Dawley rats	41435
@NP	the same strain of rats rather than our standard model rat Long -- Evans	41448
@NP	the same strain	41448
@NP	rats rather than our standard model rat Long -- Evans	41467
@NP	rats rather than our standard model rat Long	41467
@NP	rats	41467
@NP	our standard model rat	41484
@NP	Evans	41512
@NP	the transplantation	41532
@NP	potential cross-species	41561
@NP	tissue rejection	41585
@NP	The LP donor SD-Tg	41603
@NP	GFP	41623
@NP	2BalRrrc rats	41628
@NP	SD stock	41654
@NP	EGFP transgene	41672
@NP	ubiquitin C promoter and ubiquitous GFP expression	41692
@NP	ubiquitin C promoter	41692
@NP	ubiquitous GFP expression	41717
@NP	These rats with GFP-LP transplantation -LRB- n = 3 -RRB-	41744
@NP	These rats with GFP-LP transplantation	41744
@NP	These rats	41744
@NP	GFP-LP transplantation	41760
@NP	n	41784
@NP	3	41786
@NP	8 weeks	41803
@NP	analysis	41851
@NP	the fluorescent microscope	41866
@NP	Antibodies GFAP against astrocytes , and NF Ab-7 against neurofilaments	41894
@NP	Antibodies GFAP	41894
@NP	astrocytes , and NF Ab-7 against neurofilaments	41918
@NP	astrocytes	41918
@NP	NF Ab-7 against neurofilaments	41934
@NP	NF Ab-7	41934
@NP	neurofilaments	41950
@NP	these targets	41988
@NP	these animals	42006
@NP	4.7	42021
@NP	Histology and immunohistochemistry	42026
@NP	Histology	42026
@NP	immunohistochemistry	42040
@NP	perfusion	42079
@NP	the spinal cords	42090
@NP	the identical fixative overnight	42133
@NP	Ten mm-long cord	42167
@NP	the injury site	42203
@NP	alcohols , cleared in xylene	42250
@NP	alcohols	42250
@NP	xylene	42271
@NP	paraffin wax	42294
@NP	The cross paraffin sections -LRB- 10 μm thick -RRB-	42308
@NP	The cross paraffin sections	42308
@NP	10 μm	42337
@NP	the injury epicenter	42362
@NP	routinely -LRB- hematoxylin and eosin , H.E. -RRB-	42395
@NP	routinely	42395
@NP	hematoxylin and eosin , H.E.	42406
@NP	hematoxylin and eosin	42406
@NP	H.E.	42429
@NP	and/or	42435
@NP	immunostaining	42469
@NP	the sections	42485
@NP	xylene	42521
@NP	a series of ethanol and distilled water	42546
@NP	a series	42546
@NP	ethanol and distilled water	42558
@NP	Sections	42587
@NP	the Antigen Retrieval Citra solution -LRB- BioGenex , San Ramon , CA -RRB-	42611
@NP	the Antigen Retrieval Citra solution	42611
@NP	BioGenex	42649
@NP	San Ramon	42659
@NP	CA	42670
@NP	15 min	42678
@NP	the endogenous peroxidase	42696
@NP	the sections	42722
@NP	3 % H2O2	42755
@NP	50 mM Tris-buffered saline	42766
@NP	0.1 % Triton X-100 -LRB- TTBS -RRB- pH 7.5	42804
@NP	0.1 % Triton X-100 -LRB- TTBS -RRB-	42804
@NP	0.1 % Triton X-100	42804
@NP	TTBS	42823
@NP	30 min at room temperature	42841
@NP	30 min	42841
@NP	room temperature	42851
@NP	RT	42869
@NP	The normal goat serum -LRB- 2 % in TTBS -RRB-	42874
@NP	The normal goat serum	42874
@NP	2 % in TTBS	42897
@NP	2 %	42897
@NP	TTBS	42903
@NP	60 min	42920
@NP	RT	42930
@NP	the tissue to block non-specific antigens	42937
@NP	non-specific antigens	42957
@NP	primary antibodies	43001
@NP	TTBS with 1 % normal goat serum	43031
@NP	TTBS	43031
@NP	1 % normal goat serum	43041
@NP	a humidified chamber overnight	43065
@NP	RT	43099
@NP	the sections	43103
@NP	1:200	43145
@NP	goat anti-mouse IgG -LRB- Jackson -RRB- for 60 min and then	43164
@NP	goat anti-mouse IgG -LRB- Jackson -RRB-	43164
@NP	goat anti-mouse IgG	43164
@NP	Jackson	43185
@NP	60 min and then	43198
@NP	60 min	43198
@NP	then	43209
@NP	1:500 streptavidin peroxidase -LRB- Jackson -RRB-	43217
@NP	1:500 streptavidin peroxidase	43217
@NP	Jackson	43248
@NP	60 min in the same buffer	43261
@NP	60 min	43261
@NP	the same buffer	43271
@NP	The immunoreactive product was visualized by incubating in 3,3 ′	43288
@NP	The immunoreactive product	43288
@NP	3,3 ′	43347
@NP	3,3	43347
@NP	diaminobenzidine solution -LRB- DAB , 0.5 mg in 1 ml TTBS -RRB-	43352
@NP	diaminobenzidine solution	43352
@NP	DAB , 0.5 mg in 1 ml TTBS	43379
@NP	DAB	43379
@NP	0.5 mg in 1 ml TTBS	43384
@NP	0.5 mg	43384
@NP	1 ml TTBS	43394
@NP	0.01 % H2O2 for 1	43409
@NP	0.01 % H2O2	43409
@NP	1	43424
@NP	3 min	43426
@NP	3	43426
@NP	min	43428
@NP	The sections	43433
@NP	hematoxylin	43525
@NP	Negative controls	43538
@NP	the lack of the primary antibody	43587
@NP	the lack	43587
@NP	the primary antibody	43599
@NP	The primary antibodies used for the paraffin sections	43621
@NP	The primary antibodies	43621
@NP	the paraffin sections	43653
@NP	monoclonal antibody	43679
@NP	glial fibrillary acidic protein	43707
@NP	GFAP , 1	43740
@NP	GFAP	43740
@NP	1	43746
@NP	1000 ; Neomarker , Fremont , CA	43749
@NP	1000	43749
@NP	Neomarker , Fremont , CA	43755
@NP	astrocytes	43782
@NP	monoclonal antibody P0 -LRB- 1:1000 ; courtesy of Dr.	43798
@NP	monoclonal antibody P0	43798
@NP	1:1000 ; courtesy of Dr.	43822
@NP	1:1000	43822
@NP	courtesy of Dr.	43830
@NP	courtesy	43830
@NP	Dr.	43842
@NP	Archelos , Austria -RRB- against the peripheral myelin protein .	43846
@NP	Archelos , Austria -RRB- against the peripheral myelin protein	43846
@NP	Archelos , Austria -RRB-	43846
@NP	Archelos	43846
@NP	the peripheral myelin protein	43873
@NP	4.8	43904
@NP	Quantitative analysis	43909
@NP	tissue repair	43934
@NP	the changes	43974
@NP	tissues and lesion cavities	43998
@NP	size	44029
@NP	the whole area	44035
@NP	the areas of spared tissues	44055
@NP	the areas	44055
@NP	spared tissues	44068
@NP	tissues and lesion cavities	44093
@NP	the cross sections	44149
@NP	the injury epicenter in each case	44173
@NP	the injury epicenter	44173
@NP	each case	44197
@NP	The paraffin sectionswere stainedwith hematoxylin and eosin	44208
@NP	the Soft Imaging System GmbH	44272
@NP	Version 1.20	44302
@NP	Olympus	44316
@NP	measurement	44338
@NP	The average percentage	44351
@NP	spared tissues	44377
@NP	tissues and lesion cavities	44402
@NP	the whole area of cross section in each group	44433
@NP	the whole area	44433
@NP	cross section in each group	44451
@NP	cross section	44451
@NP	each group	44468
@NP	mean ± SEM	44497
@NP	the comparisons between groups	44511
@NP	the comparisons	44511
@NP	groups	44535
@NP	The number for areameasurement in each group	44558
@NP	The number	44558
@NP	areameasurement in each group	44573
@NP	areameasurement	44573
@NP	each group	44592
@NP	the same as that for P0-positive myelin sheath counting	44606
@NP	that for P0-positive myelin sheath	44618
@NP	that	44618
@NP	P0-positive myelin sheath	44627
@NP	4.9	44663
@NP	P0-positive myelin sheath counting	44668
@NP	the present study	44706
@NP	the number of P0-positive myelin sheaths	44725
@NP	the number	44725
@NP	P0-positive myelin sheaths	44739
@NP	the light microscope -LRB- magnification : 30 × -RRB-	44784
@NP	the light microscope	44784
@NP	magnification : 30 ×	44806
@NP	magnification	44806
@NP	30 ×	44821
@NP	The area counted	44827
@NP	The area	44827
@NP	the repaired tissue	44853
@NP	lesion cavity	44874
@NP	the spared tissue	44893
@NP	the transverse sections	44914
@NP	2 -- 3 sections were counted in each case ; n ≥ 4 each group	44939
@NP	2 -- 3	44939
@NP	sections	44943
@NP	each case ; n ≥ 4 each group	44968
@NP	each case	44968
@NP	n ≥ 4 each group	44979
@NP	n	44979
@NP	≥ 4 each group	44980
@NP	the injury epicenter	44998
@NP	rats	45023
@NP	scar ablation and transplantation	45038
@NP	almost no border	45073
@NP	tissues	45139
@NP	the merging of these two different tissues	45154
@NP	the merging	45154
@NP	these two different tissues	45169
@NP	all P0-positive myelin sheaths within the areas counted	45208
@NP	all P0-positive myelin sheaths	45208
@NP	the areas counted	45246
@NP	the areas	45246
@NP	a total number for each case	45281
@NP	a total number	45281
@NP	each case	45300
@NP	4.10	45311
@NP	Evaluation of hindlimb locomotor function The neurological outcome of hind limbs	45317
@NP	Evaluation	45317
@NP	hindlimb locomotor function The neurological outcome of hind limbs	45331
@NP	hindlimb locomotor function	45331
@NP	The neurological outcome of hind limbs	45359
@NP	The neurological outcome	45359
@NP	hind limbs	45387
@NP	the well-known open field scale , BBB rating scale	45421
@NP	open field scale , BBB	45436
@NP	open field scale	45436
@NP	BBB	45454
@NP	Basso	45472
@NP	et al. , 1995 ; 1996	45478
@NP	et al.	45478
@NP	1995 ; 1996	45486
@NP	contusion injury	45505
@NP	the BBB scores	45523
@NP	1 day , 3 days , 7 days post-injury and once a week	45553
@NP	1 day	45553
@NP	3 days	45560
@NP	7 days post-injury	45568
@NP	once a week	45591
@NP	scar ablation and LP/OEC transplantation	45620
@NP	scar ablation	45620
@NP	LP/OEC transplantation	45638
@NP	the BBB scores	45662
@NP	the end of the experiment	45705
@NP	the end	45705
@NP	the experiment	45716
@NP	4.11	45732
@NP	Statistical analysis All quantitative data	45738
@NP	Statistical analysis	45738
@NP	All quantitative data	45759
@NP	mean ± SEM	45799
@NP	The analysis of all quantitative data	45809
@NP	The analysis	45809
@NP	all quantitative data	45825
@NP	one-way ANOVA for overall significance	45867
@NP	one-way ANOVA	45867
@NP	overall significance	45885
@NP	a post hoc LSD	45918
@NP	a post	45918
@NP	Student 's t test	45933
@NP	Student 's	45933
@NP	Results	45951
@NP	statistically significant at the level of p <	45975
@NP	the level of p	46004
@NP	the level	46004
@NP	p	46017
@VP	using a rose Bengal-based phototoxic method	314
@VP	may lead to functional recovery	579
@VP	lead to functional recovery	583
@VP	resulting in histological repair of damaged cord tissue at the injury epicenter	1192
@VP	was effectively prevented after ablation due to the tissue repair	1296
@VP	prevented after ablation due to the tissue repair	1312
@VP	formed by Schwann cells	1453
@VP	are known to myelinate regenerating and demyelinated axons	1484
@VP	known to myelinate regenerating and demyelinated axons	1488
@VP	known to myelinate regenerating	1488
@VP	demyelinated axons	1524
@VP	were significantly increased in number compared with the control animals	1544
@VP	increased in number compared with the control animals	1563
@VP	was not observed in this study	1716
@VP	observed in this study	1724
@VP	were discussed	1769
@VP	discussed	1774
@VP	1	1786
@VP	promote functional recovery in acute spinal cord injury -LRB- SCI -RRB- models	1887
@VP	maintain the ability to regenerate	2225
@VP	to regenerate	2246
@VP	regenerate	2249
@VP	become an important target for regeneration research in spinal cord injury	3286
@VP	is mostly impractical	3676
@VP	using	3807
@VP	rose Bengal-dependent phototoxic ablation	3813
@VP	being injected into the lesion cavity	3862
@VP	injected into the lesion cavity	3868
@VP	rose Bengal was passively absorbed by the surface	3901
@VP	was passively absorbed by the surface	3913
@VP	absorbed by the surface	3927
@VP	comprising the glial scar	3975
@VP	were ablated by	4211
@VP	ablated by	4216
@VP	leading to functional recovery	4936
@VP	derived olfactory ensheathing cells -LRB- OECs -RRB-	5012
@VP	have attracted much attention from a number of investigators	5094
@VP	attracted much attention from a number of investigators	5099
@VP	derived neurotrophic factor -LRB- GDNF -RRB- -LRB- Lipson et al. , 2003 -RRB-	5619
@VP	have shown that transplanted LP OECs or olfactory bulb -LRB- OB -RRB-	5685
@VP	shown that transplanted LP OECs or olfactory bulb -LRB- OB -RRB-	5690
@VP	derived	5746
@VP	migrate after transplantation into the adult mammalian CNS	5763
@VP	to remove an olfactory bulb -LRB- Yamamoto et al. , 2009 -RRB-	6665
@VP	remove an olfactory bulb -LRB- Yamamoto et al. , 2009 -RRB-	6668
@VP	have not been well documented -LRB- Lu et al. , 2002 ; Plant et al. , 2003 -RRB-	6803
@VP	been well documented -LRB- Lu et al. , 2002 ; Plant et al. , 2003 -RRB-	6812
@VP	documented -LRB- Lu et al. , 2002 ; Plant et al. , 2003 -RRB-	6822
@VP	promote the anatomical recovery , axonal regeneration and functional recovery	7015
@VP	2	7094
@VP	used	7162
@VP	cultured OECs	7207
@VP	removed	7584
@VP	can be clearly recognized	7640
@VP	be clearly recognized	7644
@VP	clearly recognized	7647
@VP	were immunostained	7739
@VP	immunostained	7744
@VP	demonstrating expression of p75NTR -LRB- red -RRB- and GFAP -LRB- green -RRB-	7759
@VP	were stained with Hoechst -LRB- blue -RRB-	7829
@VP	stained with Hoechst -LRB- blue -RRB-	7834
@VP	pointed out by arrows -LRB- A , H.E. staining ; B , GFAP immunostaining -RRB-	7963
@VP	being injected into the lesion cavity	8049
@VP	injected into the lesion cavity	8055
@VP	were also stained in different degree	8348
@VP	stained in different degree	8358
@VP	spared tissue was stained by the rose Bengal	8409
@VP	was stained by the rose Bengal	8423
@VP	stained by the rose Bengal	8427
@VP	Following illumination	8455
@VP	damaged -LRB- area between arrows and broken line in D ; H.E. staining -RRB-	8537
@VP	has sloughed off -LRB- between arrowheads and broken line -RRB-	8633
@VP	sloughed off -LRB- between arrowheads and broken line -RRB-	8637
@VP	resulting in the spared tissue being exposed	8688
@VP	being exposed	8719
@VP	exposed	8725
@VP	is present within the lesion cavity close to the spared tissue	8754
@VP	demyelinated axons in the spared tissue	8846
@VP	are marked with asterisks -LRB- * -RRB-	8886
@VP	marked with asterisks -LRB- * -RRB-	8890
@VP	can be identified	9162
@VP	be identified	9166
@VP	identified	9169
@VP	were surrounded by the spared tissue marked by GFAP -LRB- red -RRB-	9184
@VP	surrounded by the spared tissue marked by GFAP -LRB- red -RRB-	9189
@VP	marked by GFAP -LRB- red -RRB-	9221
@VP	have their orientation parallel to the longitudinal axis of the spinal cord	9306
@VP	associated with the NF-positive axons -LRB- red in B , pointed by arrows -RRB-	9404
@VP	pointed by arrows	9453
@VP	are cross sections at the injury epicenter from different groups	9589
@VP	are their local magnifications , respectively	9686
@VP	are H.E. staining while those in the right column are GFAP immunostaining	9770
@VP	are GFAP immunostaining	9820
@VP	Spared tissue , repaired tissue and lesion cavity	9845
@VP	repaired tissue and lesion cavity	9860
@VP	are clearly marked	9894
@VP	are pointed out by arrows	9950
@VP	pointed out by arrows	9954
@VP	are all obviously observed	10187
@VP	observed	10205
@VP	are shown -LRB- mean ± SEM -RRB-	10591
@VP	shown -LRB- mean ± SEM -RRB-	10595
@VP	mean ± SEM	10602
@VP	are not prominent	10705
@VP	compared with the SCI-22w control group	10886
@VP	were present in the repaired tissue , lesion cavity	11168
@VP	spared tissue at the injury epicenter	11224
@VP	are shown	11356
@VP	shown	11360
@VP	< 0.05 ; ** : p < 0.01	11371
@VP	Note that the first two groups are 6 weeks or 22 weeks after SCI	11484
@VP	are 6 weeks or 22 weeks after SCI	11515
@VP	are all 16 weeks after secondary surgeries , i.e. , 22 weeks after SCI	11563
@VP	illustrate the distribution of P0-positive myelin sheaths at the injury site	11794
@VP	are local magnifications of A and B , respectively	11882
@VP	is local magnification of B ′	12049
@VP	found mostly in the repaired tissue , lesion cavity	12115
@VP	are presented in Fig. 7	12321
@VP	presented in Fig. 7	12325
@VP	using BBB open field scale and the BBB scores	12582
@VP	mean ± SEM	12629
@VP	are shown	12661
@VP	shown	12665
@VP	facing the lesion cavity	13253
@VP	is no clear border between the glial scar	13289
@VP	spared tissue -LRB- Fig. 2A and B ; Fig. 4A -RRB-	13335
@VP	being injected into the lesion cavity	13395
@VP	injected into the lesion cavity	13401
@VP	constitute the scar tissue	13582
@VP	were not stained by the dye	13674
@VP	stained by the dye	13683
@VP	dye	13698
@VP	were killed by phototoxicity	13767
@VP	killed by phototoxicity	13772
@VP	can be identified at the injury epicenter	14173
@VP	be identified at the injury epicenter	14177
@VP	identified at the injury epicenter	14180
@VP	limited within the lesion cavity	14232
@VP	spared tissue which was labeled by the GFAP marker -LRB- Fig. 3A -RRB-	14292
@VP	was labeled by the GFAP marker -LRB- Fig. 3A -RRB-	14312
@VP	labeled by the GFAP marker -LRB- Fig. 3A -RRB-	14316
@VP	closely associated with the GFP-positive cells -LRB- Fig. 3B -RRB-	14532
@VP	contused spinal cord -LRB- Li et al. , 2010 -RRB-	14766
@VP	is still observed at the injury site	15015
@VP	observed at the injury site	15024
@VP	is walled off from the spared tissue by the glial scar	15056
@VP	walled off from the spared tissue by the glial scar	15059
@VP	repaired tissue in size at the injury epicenter	15160
@VP	does not show significant change -LRB- Fig. 4A , A ′ , and A ″ ; Fig. 5 -RRB-	15208
@VP	show significant change -LRB- Fig. 4A , A ′ , and A ″ ; Fig. 5 -RRB-	15217
@VP	resulting in marked reduction even disappearance of the lesion cavity	15465
@VP	have successfully integrated into	15756
@VP	integrated into	15774
@VP	become a part of the repaired tissue	15794
@VP	can be found between the repaired tissue	15869
@VP	be found between the repaired tissue	15873
@VP	found between the repaired tissue	15876
@VP	spared tissue	15914
@VP	has substantially merged with the spared tissue	15965
@VP	merged with the spared tissue	15983
@VP	detected by GFAP immunostaining	16050
@VP	confirms the merging of two different tissues	16219
@VP	receiving LP or LP/OEC transplantation without scar ablation	16277
@VP	appears expanded 16 weeks after transplantation	16364
@VP	expanded 16 weeks after transplantation	16372
@VP	is shown in Fig. 5	16612
@VP	shown in Fig. 5	16615
@VP	receive no treatment -LRB- SCI-6w vs.	16752
@VP	-RRB-	16792
@VP	compared with the injury only control group -LRB- SCI-22w -RRB-	16958
@VP	repaired tissue and lesion cavity did not appear obvious change in size	17138
@VP	did not appear obvious change in size	17172
@VP	appear obvious change in size	17180
@VP	did not increase profoundly when compared with those seen 6 weeks after injury	17303
@VP	increase profoundly when compared with those seen 6 weeks after injury	17311
@VP	compared with those seen 6 weeks after injury	17336
@VP	seen 6 weeks after injury	17356
@VP	moved to	17457
@VP	to	17463
@VP	resulting in the reformation of the glial scar -LRB- Fig. 4C ′ -RRB-	17528
@VP	faces the lesion cavity	17667
@VP	was observed before	17898
@VP	observed before	17902
@VP	show prominent modification 16 weeks after transplantation -LRB- Fig. 4B ″ -RRB-	17996
@VP	occurred before being ablated disappeared	18188
@VP	being ablated	18204
@VP	disappeared	18218
@VP	implying that the glial scar no longer exists	18399
@VP	exists	18438
@VP	previously called connective tissue scar	18659
@VP	migrate from the ventral root	18937
@VP	myelinate the axons in the spared tissue of ventral portion of the cord	18971
@VP	possibly formed by the host Schwann cells	19083
@VP	were found in the repaired tissue , lesion cavity	19125
@VP	found in the repaired tissue , lesion cavity	19130
@VP	spared tissue -LRB- Fig. 6 -RRB-	19179
@VP	may include regenerating axons or demyelinated axons	19227
@VP	may include regenerating axons	19227
@VP	include regenerating axons	19231
@VP	demyelinated axons	19261
@VP	may contain both ascending and descending axons	19332
@VP	contain both ascending and descending axons	19336
@VP	ascending and descending axons	19349
@VP	is shown in Fig. 7	19430
@VP	shown in Fig. 7	19433
@VP	found 6 weeks after injury -LRB- SCI 6w : 1966 ± 433 , n = 5 -RRB-	19619
@VP	was not statistically significant when compared with the SCI control animals	19878
@VP	compared with the SCI control animals	19917
@VP	subjected to scar ablation	19961
@VP	compared with injury alone control rats	20088
@VP	evaluated using the BBB open field scale -LRB- Basso et al. , 1995 ; 1996 -RRB-	20631
@VP	using the BBB open field scale -LRB- Basso et al. , 1995 ; 1996 -RRB-	20641
@VP	receiving contusion injury only	20716
@VP	receiving LP transplantation	20920
@VP	to have BBB scores that started off at 9.27 ± 0.27 before transplantation	20969
@VP	have BBB scores that started off at 9.27 ± 0.27 before transplantation	20972
@VP	started off at 9.27 ± 0.27 before transplantation	20993
@VP	ended at 9.73 ± 0	21045
@VP	receiving LP/OEC transplantation without scar ablation	21117
@VP	receiving both scar ablation and LP transplantation	21427
@VP	receiving scar ablation and LP/OEC transplantation -LRB- n = 11 -RRB-	21609
@VP	had BBB scores changed from 9.27 ± 0.30 before transplantation to 9.45 ± 0.34	21667
@VP	changed from 9.27 ± 0.30 before transplantation to 9.45 ± 0.34	21682
@VP	3	21882
@VP	to prevent ablated glial scar from reforming	22497
@VP	prevent ablated glial scar from reforming	22500
@VP	reforming	22532
@VP	is beneficial to the tissue repair	22607
@VP	takes place after contusion injury	22668
@VP	invade the lesion cavity from the dorsal pia mater	22897
@VP	migrate into the injury epicenter from the dorsal roots	22995
@VP	myelinated or ensheathed by Schwann cells	23214
@VP	can be divided into three zones : fibrotic , cellular and axonal	23288
@VP	be divided into three zones : fibrotic , cellular and axonal	23292
@VP	divided into three zones : fibrotic , cellular and axonal	23295
@VP	regenerating axons	23475
@VP	is composed of densely compacted Schwann cells and some regenerating axons	23513
@VP	composed of densely compacted Schwann cells and some regenerating axons	23516
@VP	is thin and forms a clear U-shaped shell surrounding the fibrotic zone	23645
@VP	is thin	23645
@VP	forms a clear U-shaped shell surrounding the fibrotic zone	23657
@VP	surrounding the fibrotic zone	23686
@VP	become thick and expand in size with time or following intervention treatments	23728
@VP	become thick	23728
@VP	expand in size with time or following intervention treatments	23745
@VP	was significantly enhanced after scar ablation and LP/OEC transplantation	24286
@VP	enhanced after scar ablation and LP/OEC transplantation	24304
@VP	secreting nerve growth factors	24423
@VP	to migrate to the injury site	24488
@VP	migrate to the injury site	24491
@VP	construct the endogenous repaired tissue at the early stage	24833
@VP	repaired tissue at the early stage	24858
@VP	extended	25001
@VP	occupied most space of the lesion cavity after combination treatments	25014
@VP	survived	25132
@VP	to migrate toward and proliferate at the injury site	25182
@VP	migrate toward and proliferate at the injury site	25185
@VP	migrate toward	25185
@VP	proliferate at the injury site	25204
@VP	indirectly promoting the tissue repair	25246
@VP	repaired tissue promoted by the LP/OEC transplantation	25663
@VP	promoted by the LP/OEC transplantation	25679
@VP	leaving obvious space between repaired tissue	25766
@VP	spared tissue due to the presence of glial scar	25816
@VP	impairing the tissue integration	25870
@VP	were easily distinguished from the surrounding host tissue	26085
@VP	distinguished from the surrounding host tissue	26097
@VP	are consistent with those reported results	26307
@VP	is commonly observed	26521
@VP	observed	26533
@VP	forms two weeks after contusion injury and becomes stable and chronic afterward	26554
@VP	forms two weeks after contusion injury	26554
@VP	becomes stable and chronic	26597
@VP	facing the lesion cavity	26702
@VP	to prevent further damage of the cord tissue	26852
@VP	prevent further damage of the cord tissue	26855
@VP	observed levels of CSPGs	26990
@VP	may be reduced with time	27015
@VP	be reduced with time	27019
@VP	reduced with time	27022
@VP	determined by GFAP immunoreactivity	27089
@VP	did not show much difference -LRB- Camand et al. , 2004 -RRB-	27126
@VP	show much difference -LRB- Camand et al. , 2004 -RRB-	27134
@VP	compared with that seen 6 weeks after injury	27334
@VP	seen 6 weeks after injury	27353
@VP	fill the lesion cavity	27528
@VP	resulting in the integration of repaired tissue with the spared tissue	27552
@VP	is no integration of repaired tissue and spared tissue	27729
@VP	is no integration of repaired tissue	27729
@VP	spared tissue	27770
@VP	may be possible -LRB- Fig. 4C -RRB-	27806
@VP	be possible -LRB- Fig. 4C -RRB-	27810
@VP	may promote the P0-positive myelination	28024
@VP	promote the P0-positive myelination	28028
@VP	may ensheathe the axons -- unmyelinated fibers	28179
@VP	ensheathe the axons -- unmyelinated fibers	28183
@VP	share the same origin from the neural crest -LRB- Barraud et al. , 2010 -RRB-	28322
@VP	observed under the electron microscope in a hemisection model of rat	28523
@VP	was used for determining the axonal regeneration -LRB- Xu et al. , 1999 -RRB-	28624
@VP	used for determining the axonal regeneration -LRB- Xu et al. , 1999 -RRB-	28628
@VP	determining the axonal regeneration -LRB- Xu et al. , 1999 -RRB-	28637
@VP	formed by Schwann cells at the injury site	28711
@VP	to evaluate the trend of axonal regeneration	29135
@VP	evaluate the trend of axonal regeneration	29138
@VP	may imply the axonal regeneration	29578
@VP	imply the axonal regeneration	29582
@VP	did not result in significant locomotor recovery	29694
@VP	result in significant locomotor recovery	29702
@VP	remain unclear	29756
@VP	may be associated with poor neural plasticity below the injury	29776
@VP	be associated with poor neural plasticity below the injury	29780
@VP	associated with poor neural plasticity below the injury	29783
@VP	have not reached the target location to establish effective synaptic connection	29889
@VP	reached the target location to establish effective synaptic connection	29898
@VP	to establish effective synaptic connection	29926
@VP	establish effective synaptic connection	29929
@VP	have abnormal or non-existent impulse conduction	30031
@VP	observed a number of P0-positive myelination at the injury epicenter	30411
@VP	have reached functional locations and reestablished new synaptic connections	30515
@VP	have reached functional locations	30515
@VP	reached functional locations	30520
@VP	reestablished new synaptic connections	30553
@VP	ascending and descending	30758
@VP	to establish effective synaptic connections	30785
@VP	establish effective synaptic connections	30788
@VP	are restricted	31114
@VP	however repaired tissue	31130
@VP	is beneficial to the tissue repair	31632
@VP	did not result in significant locomotion improvement	31704
@VP	result in significant locomotion improvement	31712
@VP	are encouraging	31773
@VP	promoted by the functional electrical stimulation-based physical therapy	31860
@VP	4	31935
@VP	weighing 200	32003
@VP	were used for the present study	32022
@VP	used for the present study	32027
@VP	received contusion injury	32207
@VP	were randomly divided into several groups -LRB- Table 1 -RRB-	32237
@VP	randomly divided into several groups -LRB- Table 1 -RRB-	32242
@VP	received contusion injury only -LRB- SCI Control , i.e. , SCI 22w , n = 10 -RRB-	32310
@VP	received scar ablation/transplantation 6 weeks after SCI	32389
@VP	were processed for histological evaluation	33268
@VP	processed for histological evaluation	33273
@VP	were approved by the Institutional Animal Use and Care Committee of Colorado	33391
@VP	approved by the Institutional Animal Use and Care Committee of Colorado	33396
@VP	used Please see Table 2 for a list of all primary antibodies used in this study	33597
@VP	see Table 2 for a list of all primary antibodies used in this study	33609
@VP	used in this study	33658
@VP	is identical to that previously reported	33823
@VP	belonged to the IgG or IgM class	33911
@VP	were considered as newly formed myelin sheaths which contain an axon	34187
@VP	considered as newly formed myelin sheaths which contain an axon	34192
@VP	contain an axon	34240
@VP	recognized all axons in the spinal cord	34564
@VP	stained axons	34629
@VP	was isolated from the nasal septum of a donor animal	34859
@VP	isolated from the nasal septum of a donor animal	34863
@VP	was placed in Dispase II -LRB- Roche -RRB- for 35	34916
@VP	placed in Dispase II -LRB- Roche -RRB- for 35	34920
@VP	removed using forceps thereby exposing the LP -LRB- Fig. 1A and B -RRB-	35014
@VP	using forceps thereby exposing the LP -LRB- Fig. 1A and B -RRB-	35022
@VP	thereby exposing the LP -LRB- Fig. 1A and B -RRB-	35036
@VP	kept on ice in L-15 until transplant	35168
@VP	was used for one rat	35222
@VP	used for one rat	35226
@VP	were isolated from adult Long	35276
@VP	isolated from adult Long	35281
@VP	outlined elsewhere -LRB- Au and Roskams , 2002 -RRB-	35341
@VP	dissociated OEC culture	35388
@VP	isolated as described above	35416
@VP	described above	35428
@VP	was then sequentially passed 3 times through 22	35587
@VP	sequentially passed 3 times through 22	35596
@VP	needles into growth medium	35648
@VP	spun at 400 × g , and plated in growth	35676
@VP	spun at 400 × g	35676
@VP	plated in growth	35695
@VP	plating	35775
@VP	were removed	35803
@VP	removed	35808
@VP	were applied to the culture	35832
@VP	applied to the culture	35837
@VP	were grown for an additional 4 -- 7 days until nearly confluent	35870
@VP	grown for an additional 4 -- 7 days until nearly confluent	35875
@VP	may still contain some Schwann cells -LRB- Rizek and Kawaja , 2006 -RRB-	36039
@VP	contain some Schwann cells -LRB- Rizek and Kawaja , 2006 -RRB-	36049
@VP	were collected and frozen in liquid nitrogen in working aliquots	36101
@VP	collected and frozen in liquid nitrogen in working aliquots	36106
@VP	plated in matrigel-coated 8-well chamber slides at a density of ~ 3000 cells/cm2	36268
@VP	rinsed 1 × with PBS , fixed in 4 % paraformaldehyde and subsequently blocked	36382
@VP	rinsed 1 × with PBS	36382
@VP	fixed in 4 % paraformaldehyde	36402
@VP	subsequently blocked	36435
@VP	permeabilized with 4 % goat serum in 0.1 % Triton X-100 / PBS	36460
@VP	described before	37352
@VP	clamping the spinous process at vertebra thoracic -LRB- T -RRB- level T7 and T10	37508
@VP	was performed	37601
@VP	performed	37605
@VP	was exposed with the dura intact	37635
@VP	exposed with the dura intact	37639
@VP	was dropped on spinal cord segment T10 from a height of 25 mm	37694
@VP	dropped on spinal cord segment T10 from a height of 25 mm	37698
@VP	described previously	37808
@VP	To relieve pain	37860
@VP	relieve pain	37863
@VP	was injected twice daily for the first 2 days after injury/surgery	37918
@VP	injected twice daily for the first 2 days after injury/surgery	37922
@VP	was employed twice a day for one week	38027
@VP	employed twice a day for one week	38031
@VP	returned	38161
@VP	was paid to keep the body dry	38184
@VP	paid to keep the body dry	38188
@VP	to keep the body dry	38193
@VP	keep the body dry	38196
@VP	was administered daily for one week to prevent dehydration	38262
@VP	administered daily for one week to prevent dehydration	38266
@VP	to prevent dehydration	38298
@VP	prevent dehydration	38301
@VP	weighed daily during the first two weeks after surgery and once a week afterward	38339
@VP	lost 5 -- 10 % of their body weight during the first week after injury	38437
@VP	was more than 15 %	38532
@VP	was added	38572
@VP	added	38576
@VP	described	38748
@VP	was reopened	38848
@VP	reopened	38852
@VP	was exposed with dura intact	38900
@VP	exposed with dura intact	38904
@VP	bore	39073
@VP	connected to a Digital Microdispenser	39103
@VP	prevent damage to the cord tissue by the heating source from the halogen light	39484
@VP	To confirm the absorption of rose Bengal by glial scar cells	39706
@VP	confirm the absorption of rose Bengal by glial scar cells	39709
@VP	rose Bengal by glial scar cells	39735
@VP	rose Bengal injection into the lesion cavity without light illumination	39861
@VP	were processed for cryosection	39951
@VP	processed for cryosection	39956
@VP	rose Bengal within the lesion cavity -LRB- Fig. 2C -RRB-	40082
@VP	performed after re-opening the injury site	40179
@VP	re-opening the injury site	40195
@VP	immediately after photochemical scar ablation	40225
@VP	was incised longitudinally	40311
@VP	incised longitudinally	40315
@VP	was carefully delivered into the cavity with the help of forceps	40495
@VP	delivered into the cavity with the help of forceps	40509
@VP	connected to a Hamilton syringe prior LP delivery	40682
@VP	was closed by suturing with a 10	40753
@VP	closed by suturing with a 10	40757
@VP	suturing with a 10	40767
@VP	to reduce the invasion of connective tissue scar	40840
@VP	reduce the invasion of connective tissue scar	40843
@VP	were closed with proper sutures	40910
@VP	closed with proper sutures	40915
@VP	is ablated	40970
@VP	is located within the lesion cavity	41005
@VP	were perfused 2 h after scar ablation and LP transplantation	41051
@VP	perfused 2 h after scar ablation and LP transplantation	41056
@VP	were processed for histological observation as others -LRB- Fig. 2D -RRB-	41134
@VP	processed for histological observation as others -LRB- Fig. 2D -RRB-	41139
@VP	to confirm the survival of transplanted LP	41222
@VP	confirm the survival of transplanted LP	41225
@VP	asmentioned above	41345
@VP	were derived from a GFP-positive strain of Sprague -- Dawley rats	41384
@VP	derived from a GFP-positive strain of Sprague -- Dawley rats	41389
@VP	used for the transplantation to avoid potential cross-species tissue rejection	41523
@VP	to avoid potential cross-species tissue rejection	41552
@VP	avoid potential cross-species tissue rejection	41555
@VP	carrying EGFP transgene with ubiquitin C promoter and ubiquitous GFP expression	41663
@VP	perfused 8 weeks post-transplantation	41794
@VP	processed for analysis under the fluorescent microscope	41837
@VP	were employed to label these targets for these animals	41965
@VP	employed to label these targets for these animals	41970
@VP	to label these targets for these animals	41979
@VP	label these targets for these animals	41982
@VP	were removed and fixed in the identical fixative overnight	42107
@VP	removed and fixed in the identical fixative overnight	42112
@VP	centered on the injury site	42191
@VP	graded alcohols , cleared in xylene	42243
@VP	cleared in xylene	42260
@VP	were cut at the injury epicenter	42350
@VP	cut at the injury epicenter	42355
@VP	stained routinely -LRB- hematoxylin and eosin , H.E. -RRB- and/or	42387
@VP	deparaffinized in xylene	42503
@VP	rehydrated in a series of ethanol and distilled water	42532
@VP	To quench the endogenous peroxidase	42686
@VP	quench the endogenous peroxidase	42689
@VP	was added -LRB- 60 min at RT -RRB- to the tissue to block non-specific antigens	42909
@VP	added -LRB- 60 min at RT -RRB- to the tissue to block non-specific antigens	42913
@VP	to block non-specific antigens	42948
@VP	block non-specific antigens	42951
@VP	was visualized by incubating in 3,3 ′	43315
@VP	visualized by incubating in 3,3 ′	43319
@VP	incubating in 3,3 ′	43333
@VP	rinsed	43451
@VP	dehydrated , cleared ,	43459
@VP	coverslipped after counter-staining with hematoxylin	43484
@VP	counter-staining with hematoxylin	43503
@VP	were treated similarly , except the lack of the primary antibody	43556
@VP	treated similarly , except the lack of the primary antibody	43561
@VP	used for the paraffin sections	43644
@VP	repaired tissues and lesion cavities	44084
@VP	measured on the cross sections from the injury epicenter in each case	44137
@VP	was used for measurement	44325
@VP	used for measurement	44329
@VP	were expressed as mean ± SEM	44479
@VP	expressed as mean ± SEM	44484
@VP	were performed	44542
@VP	performed	44547
@VP	is the same as that for P0-positive myelin sheath counting	44603
@VP	was counted under the light microscope -LRB- magnification : 30 × -RRB-	44766
@VP	counted under the light microscope -LRB- magnification : 30 × -RRB-	44770
@VP	counted	44836
@VP	were counted in each case ; n ≥ 4 each group	44952
@VP	counted in each case ; n ≥ 4 each group	44957
@VP	receiving scar ablation and transplantation	45028
@VP	distinguished between repaired	45097
@VP	repaired	45119
@VP	spared tissues due to the merging of these two different tissues	45132
@VP	counted	45256
@VP	were included as a total number for each case	45264
@VP	included as a total number for each case	45269
@VP	were collected 1 day , 3 days , 7 days post-injury and once a week afterward	45538
@VP	collected 1 day , 3 days , 7 days post-injury and once a week afterward	45543
@VP	were collected weekly until the end of the experiment	45677
@VP	collected weekly until the end of the experiment	45682
@VP	were expressed as mean ± SEM	45781
@VP	expressed as mean ± SEM	45786
@VP	followed by a post hoc LSD Student 's t test	45906
@VP	were considered statistically significant at the level of p < 0.05	45959
@VP	considered statistically significant at the level of p < 0.05	45964
